<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Genomics Proteomics Bioinformatics</journal-id><journal-id journal-id-type="iso-abbrev">Genomics Proteomics Bioinformatics</journal-id><journal-id journal-id-type="pmc-domain-id">2548</journal-id><journal-id journal-id-type="pmc-domain">gpb</journal-id><journal-title-group><journal-title>Genomics, Proteomics &amp; Bioinformatics</journal-title></journal-title-group><issn pub-type="ppub">1672-0229</issn><issn pub-type="epub">2210-3244</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10025752</article-id><article-id pub-id-type="pmcid-ver">PMC10025752.1</article-id><article-id pub-id-type="pmcaid">10025752</article-id><article-id pub-id-type="pmcaiid">10025752</article-id><article-id pub-id-type="pmid">36462630</article-id><article-id pub-id-type="doi">10.1016/j.gpb.2022.11.003</article-id><article-id pub-id-type="pii">S1672-0229(22)00144-9</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Machine Learning for Lung Cancer Diagnosis, Treatment, and Prognosis</article-title></title-group><contrib-group><contrib contrib-type="author" id="au005"><name name-style="western"><surname>Li</surname><given-names initials="Y">Yawei</given-names></name><xref rid="af005" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au010"><name name-style="western"><surname>Wu</surname><given-names initials="X">Xin</given-names></name><xref rid="af010" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au015"><name name-style="western"><surname>Yang</surname><given-names initials="P">Ping</given-names></name><xref rid="af015" ref-type="aff">3</xref></contrib><contrib contrib-type="author" id="au020"><name name-style="western"><surname>Jiang</surname><given-names initials="G">Guoqian</given-names></name><xref rid="af020" ref-type="aff">4</xref></contrib><contrib contrib-type="author" id="au025"><name name-style="western"><surname>Luo</surname><given-names initials="Y">Yuan</given-names></name><email>yuan.luo@northwestern.edu</email><xref rid="af005" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp">&#8270;</xref></contrib><aff id="af005"><label>1</label>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA</aff><aff id="af010"><label>2</label>Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA</aff><aff id="af015"><label>3</label>Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905 / Scottsdale, AZ 85259, USA</aff><aff id="af020"><label>4</label>Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN 55905, USA</aff></contrib-group><author-notes><corresp id="cor1"><label>&#8270;</label>Corresponding author. <email>yuan.luo@northwestern.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>01</day><month>12</month><year>2022</year></pub-date><volume>20</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">431632</issue-id><fpage>850</fpage><lpage>866</lpage><history><date date-type="received"><day>4</day><month>3</month><year>2022</year></date><date date-type="rev-recd"><day>3</day><month>10</month><year>2022</year></date><date date-type="accepted"><day>17</day><month>11</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>12</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>21</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-13 23:25:55.330"><day>13</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2022 The Authors. Published by Elsevier B.V. and Science Press on behalf of Beijing Institute of Genomics, Chinese Academy of Sciences / China National Center for Bioinformation and Genetics Society of China.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder/><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="ab005"><p>The recent development of imaging and sequencing technologies enables systematic advances in the clinical study of lung cancer. Meanwhile, the human mind is limited in effectively handling and fully utilizing the accumulation of such enormous amounts of data. Machine learning-based approaches play a critical role in integrating and analyzing these large and complex datasets, which have extensively characterized lung cancer through the use of different perspectives from these accrued data. In this review, we provide an overview of machine learning-based approaches that strengthen the varying aspects of lung cancer diagnosis and therapy, including early detection, auxiliary diagnosis, prognosis <bold>prediction</bold>, and <bold>immunotherapy</bold> practice. Moreover, we highlight the challenges and opportunities for future applications of machine learning in lung cancer.</p></abstract><kwd-group id="kg005"><title>Keywords</title><kwd>Omics dataset</kwd><kwd>Imaging dataset</kwd><kwd>Feature extraction</kwd><kwd>Prediction</kwd><kwd>Immunotherapy</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta><notes><p id="ms005">Handled by Feng Gao</p></notes></front><body><sec id="s0005"><title>Introduction</title><p id="p0005">Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer deaths worldwide. About 2.20 million new patients are diagnosed with lung cancer each year <xref rid="b0005" ref-type="bibr">[1]</xref>, and 75% of them die within five years of diagnosis <xref rid="b0010" ref-type="bibr">[2]</xref>. High intra-tumor heterogeneity (ITH) and complexity of cancer cells giving rise to drug resistance make cancer treatment more challenging <xref rid="b0015" ref-type="bibr">[3]</xref>. Over the past decades, the continuous evolution of technologies in cancer research has contributed to many large collaborative cancer projects, which have generated numerous clinical, medical imaging, and sequencing databases <xref rid="b0020" ref-type="bibr">[4]</xref>, <xref rid="b0025" ref-type="bibr">[5]</xref>, <xref rid="b0030" ref-type="bibr">[6]</xref>. These databases facilitate researchers in investigating comprehensive patterns of lung cancer from diagnosis, treatment, and responses to clinical outcomes <xref rid="b0035" ref-type="bibr">[7]</xref>. In particular, current studies on -omics analysis, such as genomics, transcriptomics, proteomics, and metabolomics, have expanded our tools and capabilities for research. Cancer studies are undergoing a shift toward the integration of multiple data types and mega sizes. However, using diverse and high-dimensional data types for clinical tasks requires significant time and expertise even with assistance from dimension reduction methods such as matrix and tensor factorizations <xref rid="b0040" ref-type="bibr">[8]</xref>, <xref rid="b0045" ref-type="bibr">[9]</xref>, <xref rid="b0050" ref-type="bibr">[10]</xref>, <xref rid="b0055" ref-type="bibr">[11]</xref>, and analyzing the exponentially growing cancer-associated databases poses a major challenge to researchers. Therefore, using machine learning (ML) models to automatically learn the internal characteristics of different data types to assist physicians&#8217; decision-making has become increasingly important.</p><p id="p0010">ML is a subgroup of artificial intelligence (AI) that focuses on making predictions by identifying patterns in data using mathematical algorithms <xref rid="b0060" ref-type="bibr">[12]</xref>. It has served as an assisting tool in cancer phenotyping and therapy for decades <xref rid="b0065" ref-type="bibr">[13]</xref>, <xref rid="b0070" ref-type="bibr">[14]</xref>, <xref rid="b0075" ref-type="bibr">[15]</xref>, <xref rid="b0080" ref-type="bibr">[16]</xref>, <xref rid="b0085" ref-type="bibr">[17]</xref>, <xref rid="b0090" ref-type="bibr">[18]</xref>, <xref rid="b0095" ref-type="bibr">[19]</xref>, and has been widely implemented in advanced approaches for early detection, cancer type classification, signature extraction, tumor microenvironment (TME) deconvolution, prognosis prediction, and drug response evaluation <xref rid="b0100" ref-type="bibr">[20]</xref>, <xref rid="b0105" ref-type="bibr">[21]</xref>, <xref rid="b0110" ref-type="bibr">[22]</xref>, <xref rid="b0115" ref-type="bibr">[23]</xref>, <xref rid="b0120" ref-type="bibr">[24]</xref>, <xref rid="b0125" ref-type="bibr">[25]</xref>, <xref rid="b0130" ref-type="bibr">[26]</xref>, <xref rid="b0135" ref-type="bibr">[27]</xref>. Herein, we present an overview of the main ML algorithms that have been used to integrate complex biomedical data (<italic toggle="yes">e.g.</italic>, imaging or sequencing data) for different aspects of lung cancer (<xref rid="f0005" ref-type="fig">Figure 1</xref>; Tables S1 and S2), and outline major challenges and opportunities for future applications of ML in lung cancer clinical research and practice. We hope that this review promotes a better understanding of the roles and potentialities of ML in this field.<fig id="f0005" position="float" orientation="portrait"><label>Figure 1</label><caption><p><bold>Applications of ML model in lung cancer</bold></p><p>We presented an overview of ML methodologies for different aspects of lung cancer therapies, including CAD from imaging datasets, lung cancer early detection based on sequencing technologies, data integration and biomarker extraction from multi-omics datasets, treatment response and prognosis prediction, and immunotherapy studies. ML, machine learning; IC50, half-maximal inhibitory concentration; HLA, human leukocyte antigen; CT, computed tomography; MALDI, matrix-assisted laser desorption/ionization; DL, deep learning; cfDNA, cell-free DNA; CAD, computer-aided diagnosis; CNV, copy number variation; RECIST, Response Evaluation Criteria in Solid Tumors; TIL, tumor-infiltrating lymphocyte.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p></sec><sec id="s0010"><title>Apply ML for early detection and auxiliary diagnosis of lung cancer</title><sec id="s0015"><title>ML on early detection and diagnosis using medical imaging datasets</title><p id="p0015">Early diagnosis is an important procedure for reducing deaths related to lung cancer. Chest screening using low-dose computed tomography (CT) is the primary approach for the surveillance of people with increased lung cancer risk. To promote diagnostic efficiency, the computer-aided diagnosis (CAD) system was developed to assist physicians in the interpretation of medical imaging data <xref rid="b0140" ref-type="bibr">[28]</xref>, <xref rid="b0145" ref-type="bibr">[29]</xref>, which has been demonstrated as a useful second opinion for physicians <xref rid="b0150" ref-type="bibr">[30]</xref>. The traditional feature-based CAD task can be broken into three steps: nodule segmentation, feature extraction and selection, and clinical judgment inference (classification) (<xref rid="f0010" ref-type="fig">Figure 2</xref>). Some approaches apply the measured texture features of specified nodules in CT images combined with the patient&#8217;s clinical variables as input features to train an ML classifier, including logistic regression (LR) <xref rid="b0155" ref-type="bibr">[31]</xref>, <xref rid="b0160" ref-type="bibr">[32]</xref>, <xref rid="b0165" ref-type="bibr">[33]</xref> or linear discriminant analysis (LDA) <xref rid="b0170" ref-type="bibr">[34]</xref>, for malignancy risk estimation. Typically, these measurements include nodule size, nodule type, nodule location, nodule count, nodule boundary, and emphysema information in CT images, and the clinical variables include the patient&#8217;s age, gender, specimen collection timing, family history of lung cancer, smoking exposure, and more. However, these features are mostly subjective and arbitrarily defined, and usually fail to achieve a complete and quantitative description of malignant nodule appearances.<fig id="f0010" position="float" orientation="portrait"><label>Figure 2</label><caption><p><bold>Feature-based CAD and DL-based CAD systems</bold></p><p>Differences in the development process of feature-based CAD systems and CNN-based CAD systems. Compared with feature-based CAD systems, the DL-based CAD systems can automatically retrieve and extract intrinsic features of a suspicious nodule. CNN, convolutional neural network; LR, logistic regression; SVM, support vector machine; RF, random forest.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr2.jpg"/></fig></p><p id="p0020">With the development of deep learning (DL) algorithms, especially convolutional neural networks (CNNs), more studies have been conducted to apply DL-based models in the CAD system to improve its accuracy and reduce its false positive rate and execution time during lung tumor detection (<xref rid="t0005" ref-type="table">Table 1</xref>) <xref rid="b0175" ref-type="bibr">[35]</xref>, <xref rid="b0180" ref-type="bibr">[36]</xref>. Similar to feature-based CAD system, the workflow of these models usually consists of three steps: nodule detection and segmentation, nodule feature extraction, and clinical judgment inference <xref rid="b0185" ref-type="bibr">[37]</xref>. Compared with traditional feature-based CAD systems, the DL-based CAD system can automatically retrieve and extract intrinsic features of a suspicious nodule <xref rid="b0190" ref-type="bibr">[38]</xref>, <xref rid="b0195" ref-type="bibr">[39]</xref>, and can model the 3D shape of a nodule (<xref rid="f0010" ref-type="fig">Figure 2</xref>). For example, Ciompi et al. <xref rid="b0200" ref-type="bibr">[40]</xref> designed a model based on OverFeat <xref rid="b0205" ref-type="bibr">[41]</xref>, <xref rid="b0210" ref-type="bibr">[42]</xref> by extracting three 2D-view-feature vectors (axial, coronal, and sagittal) of the nodule from CT scans. The recently integrated CNN models facilitate a global and comprehensive inspection of nodules for feature characterization from CT images. Buty et al. <xref rid="b0185" ref-type="bibr">[37]</xref> designed a complementary CNN model, where a spherical harmonic model <xref rid="b0215" ref-type="bibr">[43]</xref> for nodule segmentation was used to obtain the shape descriptions (&#8220;shape&#8221; feature) of the segmented nodule and a deep convolutional neural network (DCNN)-based model <xref rid="b0205" ref-type="bibr">[41]</xref> to extract the texture and intensity features (&#8220;appearance&#8221; feature) of the nodule. The downstream classification relied on the combination of &#8220;shape&#8221; and &#8220;appearance&#8221; features. Similarly, Venkadesh et al. <xref rid="b0220" ref-type="bibr">[44]</xref> used an ensemble model from two different models, 2D-ResNet50-based <xref rid="b0225" ref-type="bibr">[45]</xref> and 3D-Inception-V1 <xref rid="b0230" ref-type="bibr">[46]</xref>, to respectively extract two features of a pulmonary nodule, and then concatenated the two features as the input features for classification. A superiority of the ensemble CNN model is that it can accurately identify malignant nodules from different sizes of nodules using the raw CT images. Benefiting from the features extracted from state-of-the-art CNN models, clinical judgment inference can be implemented through frequent ML techniques, including LR, random forest (RF), support vector machine (SVM), and neural networks (NNs). Notably, some studies also employed CNN models for final clinical judgment inference. Ardila et al. <xref rid="b0235" ref-type="bibr">[47]</xref> proposed an end-to-end approach to systematically model both localization and lung cancer risk categorization tasks using the input CT data alone. Their approach was based on a combination of three CNN models: a Mask-RCNN <xref rid="b0240" ref-type="bibr">[48]</xref> model for lung tissue segmentation, a modified RetinaNet <xref rid="b0245" ref-type="bibr">[49]</xref> model for cancer region of interest (ROI) detection, and a full-volume model based on 3D-inflated Inception-V1 <xref rid="b0250" ref-type="bibr">[50]</xref>, <xref rid="b0255" ref-type="bibr">[51]</xref> for malignancy risk prediction. In addition to CT images, CNN-based models are also widely used in histological imaging to help with lung cancer diagnosis. Compared with CT imaging, histological imaging can provide more biological information about cancer at the cellular level. To this end, AbdulJabbar et al. <xref rid="b0260" ref-type="bibr">[52]</xref> used the Micro-Net <xref rid="b0265" ref-type="bibr">[53]</xref> model to identify tissue boundaries followed by an SC-CNN <xref rid="b0270" ref-type="bibr">[54]</xref> model to segment individual cells from hematoxylin and eosin (H&amp;E)-stained and immunohistochemistry (IHC) images. The segmented cells were then applied for cell type classification to evaluate the proportions of each cell type in the images. This model helps to identify the differential evolution and immune evasion mechanisms between lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) with high resolution. Another study <xref rid="b0275" ref-type="bibr">[55]</xref> utilized the Inception-V3 network <xref rid="b0255" ref-type="bibr">[51]</xref> to classify whether the tissue was LUAD, LUSC, or normal from H&amp;E-stained histopathology whole-slide images. A highlight of this study is that the model can also predict whether a given tissue has somatic mutations in several lung cancer driver genes, including <italic toggle="yes">STK11</italic>, <italic toggle="yes">EGFR</italic>, <italic toggle="yes">FAT1</italic>, <italic toggle="yes">SETBP1</italic>, <italic toggle="yes">KRAS</italic>, and <italic toggle="yes">TP53</italic>. Note that considering the high complexity and large resources of the datasets, some studies utilized transfer learning to improve their efficiency and robustness when training new models <xref rid="b0190" ref-type="bibr">[38]</xref>, <xref rid="b0275" ref-type="bibr">[55]</xref>.<table-wrap position="float" id="t0005" orientation="portrait"><label>Table 1</label><caption><p><bold>Publications relevant to</bold><bold>ML</bold><bold>on early detection and diagnosis using imaging data</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"><bold>Publication</bold></th><th colspan="1" rowspan="1"><bold>Feature extraction</bold></th><th colspan="1" rowspan="1"><bold>Classification model</bold></th><th colspan="1" rowspan="1"><bold>Sample size</bold></th><th colspan="1" rowspan="1"><bold>Imaging data type</bold></th><th colspan="1" rowspan="1"><bold>Performance</bold></th><th colspan="1" rowspan="1"><bold>Validation method</bold></th><th colspan="1" rowspan="1"><bold>Feature selection/input</bold></th><th colspan="1" rowspan="1"><bold>Highlight</bold><bold>/</bold>a<bold>dvantage</bold></th><th colspan="1" rowspan="1"><bold>Shortcoming</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1">McWilliams et al. <xref rid="b0155" ref-type="bibr">[31]</xref></td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">LR</td><td colspan="1" rowspan="1">2961</td><td colspan="1" rowspan="1">CT images</td><td colspan="1" rowspan="1">AUC (0.907&#8211;0.960)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">Clinical risk factors&#160;+&#160;nodule characteristics on CT images</td><td colspan="1" rowspan="1">Using the extracted feature as input, the classifier can achieve high AUC in small nodules (&lt; 10&#160;mm)</td><td colspan="1" rowspan="1">The selection of nodule characteristics affects the predictive performance of the model</td></tr><tr><td colspan="1" rowspan="1">Riel et al. <xref rid="b0160" ref-type="bibr">[32]</xref></td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">LR</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">CT images</td><td colspan="1" rowspan="1">AUC (0.706&#8211;0.932)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">Clinical factors&#160;+&#160;nodule characteristics on CT images</td><td colspan="1" rowspan="1">The classifier can perform equivalently as human observers for malignant and benign classification</td><td colspan="1" rowspan="1">The performance heavily relies on nodule size as the discriminator, and is not robust in small nodules</td></tr><tr><td colspan="1" rowspan="1">Kriegsmann et al. <xref rid="b0170" ref-type="bibr">[34]</xref></td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">LDA</td><td colspan="1" rowspan="1">326</td><td colspan="1" rowspan="1">MALDI</td><td colspan="1" rowspan="1">Accuracy (0.991)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">Mass spectra from ROIs of MALDI image</td><td colspan="1" rowspan="1">The model maintains high accuracy on FFPE biopsies</td><td colspan="1" rowspan="1">The performance relies on the quality of the MALDI stratification</td></tr><tr><td colspan="1" rowspan="1">Buty et al. <xref rid="b0185" ref-type="bibr">[37]</xref></td><td colspan="1" rowspan="1">Spherical harmonics <xref rid="b0220" ref-type="bibr">[44]</xref>;<break/>DCNN <xref rid="b0205" ref-type="bibr">[41]</xref></td><td colspan="1" rowspan="1">RF</td><td colspan="1" rowspan="1">1018</td><td colspan="1" rowspan="1">CT images</td><td colspan="1" rowspan="1">Accuracy (0.793&#8211;0.824)</td><td colspan="1" rowspan="1">10-fold cross-validation</td><td colspan="1" rowspan="1">CT imaging patches&#160;+&#160;radiologists&#8217; binary nodule segmentations</td><td colspan="1" rowspan="1">The model reaches higher predictive accuracy by integrating shape and appearance nodule imaging features</td><td colspan="1" rowspan="1">No benchmarking comparisons were used in the study</td></tr><tr><td colspan="1" rowspan="1">Hussein et al. <xref rid="b0190" ref-type="bibr">[38]</xref></td><td colspan="1" rowspan="1">3D CNN-based multi-task model</td><td colspan="1" rowspan="1">3D CNN-based multi-task model</td><td colspan="1" rowspan="1">1018</td><td colspan="1" rowspan="1">CT images</td><td colspan="1" rowspan="1">Accuracy (0.9126)</td><td colspan="1" rowspan="1">10-fold cross-validation</td><td colspan="1" rowspan="1">3D CT volume feature</td><td colspan="1" rowspan="1">The model achieves higher accuracy than other benchmarked models</td><td colspan="1" rowspan="1">The ground truth scores defined by radiologists for the benchmark might be arbitrary</td></tr><tr><td colspan="1" rowspan="1">Khosravan et al. <xref rid="b0195" ref-type="bibr">[39]</xref></td><td colspan="1" rowspan="1">3D CNN-based multi-task model</td><td colspan="1" rowspan="1">3D CNN-based multi-task model</td><td colspan="1" rowspan="1">6960</td><td colspan="1" rowspan="1">CT images</td><td colspan="1" rowspan="1">Segmentation DSC (0.91); classification accuracy (0.97)</td><td colspan="1" rowspan="1">10-fold cross-validation</td><td colspan="1" rowspan="1">3D CT volume feature</td><td colspan="1" rowspan="1">The model integration of clustering and sparsification algorithms helps to accurately extract potential attentional regions</td><td colspan="1" rowspan="1">Segmentation might fail if the ROIs are outside the lung regions</td></tr><tr><td colspan="1" rowspan="1">Ciompi et al. <xref rid="b0200" ref-type="bibr">[40]</xref></td><td colspan="1" rowspan="1">OverFeat <xref rid="b0210" ref-type="bibr">[42]</xref></td><td colspan="1" rowspan="1">SVM; RF</td><td colspan="1" rowspan="1">1729</td><td colspan="1" rowspan="1">CT images</td><td colspan="1" rowspan="1">AUC (0.868)</td><td colspan="1" rowspan="1">10-fold cross-validation</td><td colspan="1" rowspan="1">3D CT volume feature, nodule position coordinate, and maximum diameter</td><td colspan="1" rowspan="1">This is the first study attempting to classify whether the diagnosed nodule is benign or malignant</td><td colspan="1" rowspan="1">The model requires specifying the position and diameter of the nodule as input, but many nodules could not be located on the CT images</td></tr><tr><td colspan="1" rowspan="1">Venkadesh et al. <xref rid="b0220" ref-type="bibr">[44]</xref></td><td colspan="1" rowspan="1">2D-ResNet50-based <xref rid="b0225" ref-type="bibr">[45]</xref>;<break/>3D-Inception-V1 <xref rid="b0230" ref-type="bibr">[46]</xref></td><td colspan="1" rowspan="1">An ensemble model based on two CNN models</td><td colspan="1" rowspan="1">16,429</td><td colspan="1" rowspan="1">CT images</td><td colspan="1" rowspan="1">AUC (0.86&#8211;0.96)</td><td colspan="1" rowspan="1">10-fold cross-validation</td><td colspan="1" rowspan="1">3D CT volume feature and nodule coordinates</td><td colspan="1" rowspan="1">The model achieves higher AUC than other benchmarked models</td><td colspan="1" rowspan="1">The model requires specifying the position of the nodule, but many nodules are unable to be located on the CT images</td></tr><tr><td colspan="1" rowspan="1">Ardila et al. <xref rid="b0235" ref-type="bibr">[47]</xref></td><td colspan="1" rowspan="1">Mask-RCNN <xref rid="b0240" ref-type="bibr">[48]</xref>;<break/>RetinaNet <xref rid="b0245" ref-type="bibr">[49]</xref>;<break/>3D-inflated Inception-V1 <xref rid="b0250" ref-type="bibr">[50]</xref>, <xref rid="b0255" ref-type="bibr">[51]</xref></td><td colspan="1" rowspan="1">Mask-RCNN <xref rid="b0240" ref-type="bibr">[48]</xref>;<break/>RetinaNet <xref rid="b0245" ref-type="bibr">[49]</xref>;<break/>3D-inflated Inception-V1 <xref rid="b0250" ref-type="bibr">[50]</xref>, <xref rid="b0255" ref-type="bibr">[51]</xref></td><td colspan="1" rowspan="1">14,851</td><td colspan="1" rowspan="1">CT images</td><td colspan="1" rowspan="1">AUC (0.944)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">Patient&#8217;s current and prior (if available) 3D CT volume features</td><td colspan="1" rowspan="1">The model achieves higher AUC than radiologists when samples do not have prior CT images</td><td colspan="1" rowspan="1">The training cohort is from only one dataset, although the sample size is large</td></tr><tr><td colspan="1" rowspan="1">AbdulJabbar et al. <xref rid="b0260" ref-type="bibr">[52]</xref></td><td colspan="1" rowspan="1">Micro-Net <xref rid="b0265" ref-type="bibr">[53]</xref>; SC-CNN <xref rid="b0270" ref-type="bibr">[54]</xref></td><td colspan="1" rowspan="1">An ensemble model based on SC-CNN <xref rid="b0270" ref-type="bibr">[54]</xref></td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Histological images</td><td colspan="1" rowspan="1">Accuracy (0.913)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">Image features of H&amp;E-stained tumor section histological slides</td><td colspan="1" rowspan="1">The model can annotate cell types at the single-cell level using histological images only</td><td colspan="1" rowspan="1">The annotation accuracy is affected by the used reference dataset</td></tr><tr><td colspan="1" rowspan="1">Coudray et al. <xref rid="b0275" ref-type="bibr">[55]</xref></td><td colspan="1" rowspan="1">Multi-task CNN model based on Inception-V3 <xref rid="b0255" ref-type="bibr">[51]</xref></td><td colspan="1" rowspan="1">Multi-task CNN model based on Inception-V3 network <xref rid="b0255" ref-type="bibr">[51]</xref></td><td colspan="1" rowspan="1">1634</td><td colspan="1" rowspan="1">Histological images</td><td colspan="1" rowspan="1">AUC (0.733&#8211;0.856)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">Transformed 512&#160;&#215;&#160;512-pixel tiles from nonoverlapping &#8216;patches&#8217; of the whole-slide images</td><td colspan="1" rowspan="1">The model can predict whether a given tissue has somatic mutations in genes <italic toggle="yes">STK11</italic>, <italic toggle="yes">EGFR</italic>, <italic toggle="yes">FAT1</italic>, <italic toggle="yes">SETBP1</italic>, <italic toggle="yes">KRAS</italic>, and <italic toggle="yes">TP53</italic></td><td colspan="1" rowspan="1">The accuracy of the gene mutation prediction is not very high</td></tr><tr><td colspan="1" rowspan="1">Lin et al. <xref rid="b0295" ref-type="bibr">[59]</xref></td><td colspan="1" rowspan="1">DCGAN <xref rid="b0290" ref-type="bibr">[58]</xref>&#160;+&#160;AlexNet <xref rid="b0205" ref-type="bibr">[41]</xref></td><td colspan="1" rowspan="1">DCGAN <xref rid="b0290" ref-type="bibr">[58]</xref>&#160;+&#160;AlexNet <xref rid="b0205" ref-type="bibr">[41]</xref></td><td colspan="1" rowspan="1">22,489</td><td colspan="1" rowspan="1">CT images</td><td colspan="1" rowspan="1">Accuracy (0.9986)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">Initial&#160;+&#160;synthetic CT images</td><td colspan="1" rowspan="1">The model uses GAN to generate synthetic lung cancer images to reduce overfitting</td><td colspan="1" rowspan="1">No benchmarking comparisons were used</td></tr><tr><td colspan="1" rowspan="1">Ren et al. <xref rid="b0300" ref-type="bibr">[60]</xref></td><td colspan="1" rowspan="1">DCGAN <xref rid="b0290" ref-type="bibr">[58]</xref>&#160;+&#160;VGG-DF</td><td colspan="1" rowspan="1">DCGAN <xref rid="b0290" ref-type="bibr">[58]</xref>&#160;+&#160;VGG-DF</td><td colspan="1" rowspan="1">15,000</td><td colspan="1" rowspan="1">Histopathological images</td><td colspan="1" rowspan="1">Accuracy (0.9984);<break/>F1-score (99.84%)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">Initial&#160;+&#160;synthetic histopathological images</td><td colspan="1" rowspan="1">The model uses GAN to generate synthetic lung cancer images and a regularization-enhanced model to reduce overfitting</td><td colspan="1" rowspan="1">The dimension of images by generator (64&#160;&#215;&#160;64) is not sufficient for biomedical domain</td></tr></tbody></table><table-wrap-foot><fn><p><italic toggle="yes">Note</italic>: ML, machine learning; NA, not applicable; LR, logistic regression; AUC, area under the curve; CT, computed tomography; LDA, linear discriminant analysis; MALDI, matrix-assisted laser desorption/ionization; ROI, region of interest; FFPE, formalin-fixed paraffin-embedded; CNN, convolutional neural network; DSC, dice similarity coefficient; SVM, support vector machine; RF, random forest; DCNN, deep convolutional neural network; SC-CNN, spatially constrained convolutional neural network; DCGAN, deep convolutional generative adversarial network; RCNN, Region-CNN; H&amp;E, hematoxylin and eosin; 2D, two dimensional; 3D, three dimensional. Compared with hold-out, cross-validation is usually more robust, and accounts for more variance between possible splits in training, validation, and test data. However, cross-validation is more time consuming than using the simple holdout method.</p></fn></table-wrap-foot></table-wrap></p><p id="p0025">Though these ML algorithms are already widely used in CAD, the challenge is that only a limited number of the images are labeled. Training a complex CNN model using a limited number of training sets may result in overfitting. Recently, generative adversarial network (GAN)-based models have been used to improve the performance of discriminative classifiers by generating pseudo images <xref rid="b0280" ref-type="bibr">[56]</xref>. Chuquicusma et al. <xref rid="b0285" ref-type="bibr">[57]</xref> first employed a deep convolutional GAN (DCGAN) <xref rid="b0290" ref-type="bibr">[58]</xref> model to generate synthetic lung nodule CT scans. With their work, more recent studies have integrated the GAN models with other CNN models to address the overfitting problem in lung cancer classification. Lin et al. <xref rid="b0295" ref-type="bibr">[59]</xref> used a two-step model &#8212; a DCGAN to generate synthetic lung cancer images and an AlexNet <xref rid="b0205" ref-type="bibr">[41]</xref> for lung cancer classification using both original and synthetic datasets. Similar work was also done by Ren and colleagues <xref rid="b0300" ref-type="bibr">[60]</xref>. They also used DCGAN <xref rid="b0290" ref-type="bibr">[58]</xref> for data augmentation. To improve performance, they then designed a regularization-enhanced transfer learning model called VGG-DF for data discrimination to prevent overfitting problems with pre-trained model auto-selection.</p></sec><sec id="s0020"><title>ML on early detection and diagnosis using -omics sequencing datasets</title><p id="p0030">Although periodic medical imaging tests are recommended for high-risk populations, implementation has been complicated by a high false discovery rate <xref rid="b0305" ref-type="bibr">[61]</xref>, <xref rid="b0310" ref-type="bibr">[62]</xref>. Therefore, there is a critical need for new techniques in early detection of lung cancers. Recent sequencing technologies enable diverse methods for early detection of lung cancer <xref rid="b0315" ref-type="bibr">[63]</xref>. In the meantime, accurately classifying lung cancer subtypes is crucial in guiding optimal therapeutic decision-making. LUAD (&#8764; 45%) and LUSC (&#8764; 25%) are the two most common subtypes of lung cancer but are often treated similarly except for targeted therapy <xref rid="b0320" ref-type="bibr">[64]</xref>. However, studies have indicated that LUAD and LUSC have drastically different biological signatures, and they have suggested that LUAD and LUSC should be classified and treated as different cancers <xref rid="b0325" ref-type="bibr">[65]</xref>, <xref rid="b0330" ref-type="bibr">[66]</xref>. From a computational perspective, both early detection and subtype identification are part of the classification task. Previous ML studies have shown the efficiency and advancement of early detection and cancer type classification in large pan-cancer sequencing datasets <xref rid="b0335" ref-type="bibr">[67]</xref>, <xref rid="b0340" ref-type="bibr">[68]</xref>, <xref rid="b0345" ref-type="bibr">[69]</xref>, <xref rid="b0350" ref-type="bibr">[70]</xref>, <xref rid="b0355" ref-type="bibr">[71]</xref>, <xref rid="b0360" ref-type="bibr">[72]</xref>, <xref rid="b0365" ref-type="bibr">[73]</xref>, <xref rid="b0370" ref-type="bibr">[74]</xref>, <xref rid="b0375" ref-type="bibr">[75]</xref>, which may provide evidence for lung cancer diagnosis. It is known that cancer cells are characterized by many genetic variations, and the accumulation of these genetic variations can be signatures that document the mutational patterns of different cancer types <xref rid="b0015" ref-type="bibr">[3]</xref>, <xref rid="b0025" ref-type="bibr">[5]</xref>, <xref rid="b0380" ref-type="bibr">[76]</xref>, <xref rid="b0385" ref-type="bibr">[77]</xref>. For this reason, recent studies have concentrated on extracting better genomic signatures as input features to boost the accuracy of their ML models. For early detection, blood-based liquid biopsy, including cell-free DNA (cfDNA) fragments, circulating tumor DNA (ctDNA), microRNA (miRNA), methylation, exosomes, and circulating tumor cells (CTCs), to explore potential circulating tumor signatures is considered a reliable method <xref rid="b0315" ref-type="bibr">[63]</xref> (<xref rid="f0015" ref-type="fig">Figure 3</xref>). Integrating these liquid biopsy signatures, many discriminative models (SVM, RF, and LR) have been used to detect tumors with high discovery rates <xref rid="b0390" ref-type="bibr">[78]</xref>, <xref rid="b0395" ref-type="bibr">[79]</xref>, <xref rid="b0400" ref-type="bibr">[80]</xref>, <xref rid="b0405" ref-type="bibr">[81]</xref>. For lung cancer subtype classification, somatic mutations, including single-nucleotide variants (SNVs), insertions, and deletions, usually have specific cancer type profiles <xref rid="b0410" ref-type="bibr">[82]</xref>. Thus, studies have leveraged somatic mutations as input features to train classifiers for LUAD&#8211;LUSC classification <xref rid="b0415" ref-type="bibr">[83]</xref>. Many of these mutations, especially driver mutations, can change expression levels, which impact gene function and interrupt cellular signaling processes <xref rid="b0410" ref-type="bibr">[82]</xref>. As a result, different cancer types show different expression levels of certain proteins <xref rid="b0420" ref-type="bibr">[84]</xref>, <xref rid="b0425" ref-type="bibr">[85]</xref>. Imposed by these unique expression profiles of cancer type, ML models can leverage RNA sequencing as input data to categorize the malignancy (benign or malignant) and subtypes (LUAD or LUSC) of patients <xref rid="b0430" ref-type="bibr">[86]</xref>, <xref rid="b0435" ref-type="bibr">[87]</xref>, <xref rid="b0440" ref-type="bibr">[88]</xref>, <xref rid="b0445" ref-type="bibr">[89]</xref>. Similarly, copy number variation (CNV) is reported to be highly correlated with differential gene expression <xref rid="b0450" ref-type="bibr">[90]</xref>, and can be ubiquitously detected in cancer cells. As such, CNVs can also be used to train ML models for cancer type classification in lung cancer studies <xref rid="b0405" ref-type="bibr">[81]</xref>, <xref rid="b0455" ref-type="bibr">[91]</xref>, <xref rid="b0460" ref-type="bibr">[92]</xref>. Note that Daemen et al. <xref rid="b0460" ref-type="bibr">[92]</xref> proposed a recurrent hidden Markov model (HMM) for the identification of extended chromosomal regions of altered copy numbers, which offers high accuracy for classification. More recently, Jurmeister et al. <xref rid="b0465" ref-type="bibr">[93]</xref> used DNA methylation profiles as input features to determine if the detected malignant nodule is primary lung cancer or the metastasis of another cancer. Directly using all generated genes as an input feature may result in overfitting <xref rid="b0470" ref-type="bibr">[94]</xref>. Thus, many studies used different computational approaches to select multiple cancer-associated genes to enhance their ML models (<xref rid="f0015" ref-type="fig">Figure 3</xref>). Some studies used ML-based algorithms for feature selection. For example, Liang et al. <xref rid="b0400" ref-type="bibr">[80]</xref> and Whitney et al. <xref rid="b0430" ref-type="bibr">[86]</xref> employed the least absolute shrinkage and selection operator (LASSO) method to select the optimal markers for model training; Aliferis et al. <xref rid="b0445" ref-type="bibr">[89]</xref> utilized recursive feature elimination (RFE) <xref rid="b0475" ref-type="bibr">[95]</xref> and univariate association filtering (UAF) models to select highly cancer-associated genes. In addition, using unsupervised models for sample population subtype clustering, and then identifying each cluster&#8217;s marker genes is also seen in many studies <xref rid="b0480" ref-type="bibr">[96]</xref>, <xref rid="b0485" ref-type="bibr">[97]</xref>. Apart from ML-based models, some studies used statistical methods for feature selection. Raman et al. <xref rid="b0405" ref-type="bibr">[81]</xref> designed a copy number profile abnormality (CPA) score to reinforce the CNV feature which is more robust and less subject to variable sample quality than directly using CNVs as the input feature. Daemen et al. <xref rid="b0460" ref-type="bibr">[92]</xref> integrated several statistical tests (ordinary fold changes, ordinary <italic toggle="yes">t</italic>-statistics, SAM-statistics, and moderated <italic toggle="yes">t</italic>-statistics) to select a robust differential expression gene set. Aside from these single-measured signatures, some studies <xref rid="b0405" ref-type="bibr">[81]</xref>, <xref rid="b0430" ref-type="bibr">[86]</xref>, <xref rid="b0440" ref-type="bibr">[88]</xref> combined the -omics signatures with clinical signatures to achieve better results. Using these tumor-type specific -omics signatures, many algorithms, K-nearest neighbors (KNN), naive Bayes (NB), SVM, decision tree (DT), LR, RF, LDA, gradient boosting, and NN, have demonstrated their ability to accurately detect and classify different lung cancer patterns (<xref rid="t0010" ref-type="table">Table 2</xref>). Note that to improve the accuracy of ML models, Kobayashi et al. <xref rid="b0415" ref-type="bibr">[83]</xref> added an element-wise input scaling for the NN model, which allows the model to maintain its accuracy with a small number of learnable parameters for optimization.<fig id="f0015" position="float" orientation="portrait"><label>Figure 3</label><caption><p><bold>Omics analysis in lung cancer studies</bold></p><p>Different sequencing techniques allow for the simultaneous measurement of multiple molecular features of a biological sample. To improve efficiency and reduce overfitting, statistical and ML tools perform differential analysis or feature selection. Further ML models concatenate the obtained omics features with clinical features as input for lung cancer diagnostic/prognostic prediction. DEG, differentially expressed gene; RFE, recursive feature elimination; UAF, univariate association filtering.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr3.jpg"/></fig><table-wrap position="float" id="t0010" orientation="portrait"><label>Table 2</label><caption><p><bold>Publications relevant to</bold><bold>ML</bold><bold>on early detection and diagnosis using sequencing data</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"><bold>Publication</bold></th><th colspan="1" rowspan="1"><bold>ML method</bold></th><th colspan="1" rowspan="1"><bold>Sample size</bold></th><th colspan="1" rowspan="1"><bold>Sequencing data type</bold></th><th colspan="1" rowspan="1"><bold>Performance</bold></th><th colspan="1" rowspan="1"><bold>Validation method</bold></th><th colspan="1" rowspan="1"><bold>Feature selection</bold></th><th colspan="1" rowspan="1"><bold>Highlight</bold><bold>/</bold>a<bold>dvantage</bold></th><th colspan="1" rowspan="1"><bold>Shortcoming</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Mathios et al. <xref rid="b0390" ref-type="bibr">[78]</xref></td><td colspan="1" rowspan="1">LR model with a LASSO penalty</td><td colspan="1" rowspan="1">799</td><td colspan="1" rowspan="1">cfDNA fragment</td><td colspan="1" rowspan="1">AUC&#8201;(0.98)</td><td colspan="1" rowspan="1">10-fold cross-validation</td><td colspan="1" rowspan="1">cfDNA fragment features, clinical risk factors, and CT imaging features</td><td colspan="1" rowspan="1">This study provides a framework for combining cfDNA fragmentation profiles with other markers for lung cancer detection</td><td colspan="1" rowspan="1">DNA variations in late-stage disease may affect cfDNA detection</td></tr><tr><td colspan="1" rowspan="1">Lung-CLiP <xref rid="b0395" ref-type="bibr">[79]</xref></td><td colspan="1" rowspan="1">5-nearest neighbor; 3-nearest neighbor; NB; LR; DT</td><td colspan="1" rowspan="1">160</td><td colspan="1" rowspan="1">cfDNA</td><td colspan="1" rowspan="1">AUC (0.69&#8211;0.98)</td><td colspan="1" rowspan="1">Leave-one-out cross-validation</td><td colspan="1" rowspan="1">SNV&#160;+&#160;CNV features</td><td colspan="1" rowspan="1">This study establishes an ML framework for the early detection of lung cancers using cfDNA</td><td colspan="1" rowspan="1">Sampling bias exists (most are smokers) in the training dataset</td></tr><tr><td colspan="1" rowspan="1">Liang et al. <xref rid="b0400" ref-type="bibr">[80]</xref></td><td colspan="1" rowspan="1">LR</td><td colspan="1" rowspan="1">296</td><td colspan="1" rowspan="1">ctDNA</td><td colspan="1" rowspan="1">AUC (0.816)</td><td colspan="1" rowspan="1">10-fold cross-validation</td><td colspan="1" rowspan="1">Nine DNA methylation markers</td><td colspan="1" rowspan="1">This study establishes an ML framework for the early detection of lung cancers using DNA methylation markers</td><td colspan="1" rowspan="1">The selected features are comprised of only nine methylation biomarkers, which poses a limitation on assay performance</td></tr><tr><td colspan="1" rowspan="1">Raman et al. <xref rid="b0405" ref-type="bibr">[81]</xref></td><td colspan="1" rowspan="1">RF; SVM; LR with ridge, elastic net; LASSO regularization</td><td colspan="1" rowspan="1">843</td><td colspan="1" rowspan="1">cfDNA</td><td colspan="1" rowspan="1">mAUC (0.896&#8211;0.936)</td><td colspan="1" rowspan="1">Leave-one-out cross-validation</td><td colspan="1" rowspan="1">Copy number profiling of cfDNA</td><td colspan="1" rowspan="1">The model provides a framework for using copy number profiling of cfDNA as a biomarker in lung cancer detection</td><td colspan="1" rowspan="1">Feature selection methods can be used to reduce overfitting and may have the potential to achieve higher AUC</td></tr><tr><td colspan="1" rowspan="1">Kobayashi et al. <xref rid="b0415" ref-type="bibr">[83]</xref></td><td colspan="1" rowspan="1">Diet Networks with EIS</td><td colspan="1" rowspan="1">954</td><td colspan="1" rowspan="1">Somatic mutation</td><td colspan="1" rowspan="1">Accuracy (0.8)</td><td colspan="1" rowspan="1">5-fold cross-validation</td><td colspan="1" rowspan="1">SNVs, insertions, and deletions across 1796 genes</td><td colspan="1" rowspan="1">The EIS helps to stabilize the training process of Diet Networks</td><td colspan="1" rowspan="1">The interpretable hidden interpretations obtained from EIS may vary between different datasets</td></tr><tr><td colspan="1" rowspan="1">Whitney et al. <xref rid="b0430" ref-type="bibr">[86]</xref></td><td colspan="1" rowspan="1">LR</td><td colspan="1" rowspan="1">299</td><td colspan="1" rowspan="1">RNA-seq of BECs</td><td colspan="1" rowspan="1">AUC (0.81)</td><td colspan="1" rowspan="1">10-fold cross-validation</td><td colspan="1" rowspan="1">Lung cancer-associated and clinical covariate RNA markers</td><td colspan="1" rowspan="1">The model keeps sensitivity for small and peripheral suspected lesions</td><td colspan="1" rowspan="1">The selected genes vary greatly under different feature selection processes and parameters</td></tr><tr><td colspan="1" rowspan="1">Podolsky et al. <xref rid="b0435" ref-type="bibr">[87]</xref></td><td colspan="1" rowspan="1">KNN; NB normal distribution of attributes; NB distribution through histograms; SVM; C4.5 DT</td><td colspan="1" rowspan="1">529</td><td colspan="1" rowspan="1">RNA-seq</td><td colspan="1" rowspan="1">AUC (0.91)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">RNA-seq</td><td colspan="1" rowspan="1">This study systematically compares different models of lung cancer subtype classification across different datasets</td><td colspan="1" rowspan="1">Feature selection methods can be used to reduce overfitting</td></tr><tr><td colspan="1" rowspan="1">Choi et al. <xref rid="b0440" ref-type="bibr">[88]</xref></td><td colspan="1" rowspan="1">An ensemble model based on elastic net LR; SVM; hierarchical LR</td><td colspan="1" rowspan="1">2285</td><td colspan="1" rowspan="1">RNA-seq of bronchial brushing samples</td><td colspan="1" rowspan="1">AUC (0.74)</td><td colspan="1" rowspan="1">5-fold cross-validation</td><td colspan="1" rowspan="1">RNA-seq of 1232 genes with clinical covariates</td><td colspan="1" rowspan="1">The model integrates RNA-seq features and clinical information to improve the accuracy of risk prediction</td><td colspan="1" rowspan="1">Sample sizes in certain subgroups are small and may cause unbalanced training</td></tr><tr><td colspan="1" rowspan="1">Aliferis et al. <xref rid="b0445" ref-type="bibr">[89]</xref></td><td colspan="1" rowspan="1">Linear SVM; polynomial-kernel SVM; KNN; NN</td><td colspan="1" rowspan="1">203</td><td colspan="1" rowspan="1">RNA-seq</td><td colspan="1" rowspan="1">AUC (0.8783&#8211;0.9980)</td><td colspan="1" rowspan="1">5-fold cross-validation</td><td colspan="1" rowspan="1">RNA-seq of selected genes using RFE and UAF</td><td colspan="1" rowspan="1">The study uses different gene selection algorithms to improve the classification accuracy</td><td colspan="1" rowspan="1">The selected genes vary greatly across different training cohorts</td></tr><tr><td colspan="1" rowspan="1">Aliferis et al. <xref rid="b0455" ref-type="bibr">[91]</xref></td><td colspan="1" rowspan="1">DT; KNN; linear SVM; polynomial-kernel SVM; RBF-kernel SVM; NN</td><td colspan="1" rowspan="1">37</td><td colspan="1" rowspan="1">CNV measured by CGH</td><td colspan="1" rowspan="1">Accuracy (0.892)</td><td colspan="1" rowspan="1">Leave-one-out cross-validation</td><td colspan="1" rowspan="1">Copy number of 80 selected genes based on linear SVM</td><td colspan="1" rowspan="1">The study systematically compares different models of lung cancer subtype classification</td><td colspan="1" rowspan="1">The sample size is small</td></tr><tr><td colspan="1" rowspan="1">Daemen et al. <xref rid="b0460" ref-type="bibr">[92]</xref></td><td colspan="1" rowspan="1">HMM; weighted LS-SVM</td><td colspan="1" rowspan="1">89</td><td colspan="1" rowspan="1">CNV measured by CGH</td><td colspan="1" rowspan="1">Accuracy (0.880&#8211;0.955)</td><td colspan="1" rowspan="1">10-fold cross-validation</td><td colspan="1" rowspan="1">CNV measured by CGH</td><td colspan="1" rowspan="1">The use of recurrent HMMs for CNV detection provides high accuracy for cancer classification</td><td colspan="1" rowspan="1">Benchmarked comparisons are needed to demonstrate the superiority of using the HMM model</td></tr><tr><td colspan="1" rowspan="1">Jurmeister et al. <xref rid="b0465" ref-type="bibr">[93]</xref></td><td colspan="1" rowspan="1">NN; SVM; RF</td><td colspan="1" rowspan="1">972</td><td colspan="1" rowspan="1">DNA methylation</td><td colspan="1" rowspan="1">Accuracy (0.878&#8211;0.964)</td><td colspan="1" rowspan="1">5-fold cross-validation</td><td colspan="1" rowspan="1">Top 2000 variable CpG sites</td><td colspan="1" rowspan="1">The study provides a framework for using DNA methylation data to predict tumor metastases</td><td colspan="1" rowspan="1">The model cannot accurately predict samples with low tumor cellularity through methylation data</td></tr></tbody></table><table-wrap-foot><fn><p><italic toggle="yes">Note</italic>: LASSO, least absolute shrinkage and selection operator; cfDNA, cell-free DNA; NB, naive Bayes; DT, decision tree; SNV, single-nucleotide variant; CNV, copy number variation; ctDNA, circulating tumor DNA; mAUC, mean area under the curve; EIS, element-wise input scaling; BEC, bronchial epithelial cell; KNN, K-nearest neighbors; NN, neural network; RFE, recursive feature elimination; UAF, univariate association filtering; CGH, comparative genomic hybridization; HMM, hidden Markov model; LS-SVM, least squares support vector machines; RNA-seq, RNA sequencing. Compared with hold-out, cross-validation is usually more robust, and accounts for more variance between possible splits in training, validation, and test data. However, cross-validation is more time consuming than using the simple holdout method.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec id="s0025"><title>Apply ML to lung cancer treatment response and survival prediction</title><sec id="s0030"><title>Prognosis and therapy response prediction</title><p id="p0035">Sophisticated ML models have acted as supplements for cancer intervention response evaluation and prediction <xref rid="b0490" ref-type="bibr">[98]</xref>, <xref rid="b0495" ref-type="bibr">[99]</xref>, and have demonstrated advances in optimizing therapy decisions that improve chances of successful recovery (<xref rid="f0020" ref-type="fig">Figure 4</xref>; <xref rid="t0015" ref-type="table">Table 3</xref>) <xref rid="b0500" ref-type="bibr">[100]</xref>, <xref rid="b0505" ref-type="bibr">[101]</xref>. There are several metrics that are available for evaluating cancer therapy response, including the Response Evaluation Criteria in Solid Tumors (RECIST) <xref rid="b0510" ref-type="bibr">[102]</xref>. The definition of RECIST relies on imaging data, mainly CT and magnetic resonance imaging (MRI), to determine how tumors grow or shrink in patients <xref rid="b0515" ref-type="bibr">[103]</xref>. To track the tumor volume changes from CT images, Jiang et al. <xref rid="b0520" ref-type="bibr">[104]</xref> designed an integrated CNN model. Their CNN model used two deep networks based on a full-resolution residual network <xref rid="b0525" ref-type="bibr">[105]</xref> model by adding multiple residual streams of varying resolutions, so that they could simultaneously combine features at different resolutions for segmenting lung tumors. Using the RECIST criterion, Qureshi <xref rid="b0530" ref-type="bibr">[106]</xref> set up a RF model to predict the RECIST level under EGFR tyrosine kinase inhibitor (TKI) therapy given the patient&#8217;s mutation profile in gene <italic toggle="yes">EGFR</italic>. To improve the prediction performance, the model integrated clinical information, geometrical features, and energy features obtained from a patient&#8217;s <italic toggle="yes">EGFR</italic> mutant drug complex as input to train the classifiers. In a recent study, the authors defined a different metric, tumor proportional scoring (TPS) calculated as the percentage of tumor cells in digital pathology images, to evaluate the lung cancer treatment response <xref rid="b0535" ref-type="bibr">[107]</xref>. They applied the Otsu threshold <xref rid="b0540" ref-type="bibr">[108]</xref> with an auxiliary classifier generative adversarial network (AC-GAN) model to identify positive tumor cell regions (TC<sup>+</sup>) and negative tumor cell regions (TC<sup>&#8722;</sup>). And they ultimately used the ratio between the pixel count of the TC<sup>+</sup> regions and the pixel count of all detected tumor cell regions to evaluate the TPS number. Another study from Geeleher et al. <xref rid="b0545" ref-type="bibr">[109]</xref> used half-maximal inhibitory concentration (IC50) to evaluate drug response. In their model, the authors applied a ridge regression model <xref rid="b0550" ref-type="bibr">[110]</xref> to estimate IC50 values for different cell lines in terms of their whole-genome expression level. More recently, Quiros et al. <xref rid="b0555" ref-type="bibr">[111]</xref> established a phenotype representation learning (PRL) through self-supervised learning and community detection for spatial clustering cell type annotation on histopathological images. Their clustering results can be further used for tracking histological tumor growth patterns and identifying tumor recurrence. Indeed, their model has also demonstrated good performance in the LUAD and LUSC classifications.<fig id="f0020" position="float" orientation="portrait"><label>Figure 4</label><caption><p><bold>Diagram of ML applications in treatment response and survival prediction</bold></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr4.jpg"/></fig><table-wrap position="float" id="t0015" orientation="portrait"><label>Table 3</label><caption><p><bold>Publications relevant to</bold><bold>ML</bold><bold>on treatment response and survival prediction</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"><bold>Publication</bold></th><th colspan="1" rowspan="1"><bold>Feature extraction method</bold></th><th colspan="1" rowspan="1"><bold>Prediction model</bold></th><th colspan="1" rowspan="1"><bold>Sample size</bold></th><th colspan="1" rowspan="1"><bold>Data type</bold></th><th colspan="1" rowspan="1"><bold>Performance</bold></th><th colspan="1" rowspan="1"><bold>Validation method</bold></th><th colspan="1" rowspan="1"><bold>Feature selection/</bold>i<bold>nput</bold></th><th colspan="1" rowspan="1"><bold>Highlight</bold><bold>/</bold>a<bold>dvantage</bold></th><th colspan="1" rowspan="1"><bold>Shortcoming</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Jiang et al. <xref rid="b0520" ref-type="bibr">[104]</xref></td><td colspan="1" rowspan="1">MRRN-based model</td><td colspan="1" rowspan="1">MRRN-based model</td><td colspan="1" rowspan="1">1210</td><td colspan="1" rowspan="1">CT Images</td><td colspan="1" rowspan="1">DSC (0.68&#8211;0.75)</td><td colspan="1" rowspan="1">5-fold cross-validation</td><td colspan="1" rowspan="1">3D image features</td><td colspan="1" rowspan="1">The model can accurately track the tumor volume changes from CT images across multiple image resolutions</td><td colspan="1" rowspan="1">The model does not predict accurately enough when the tumor size is small</td></tr><tr><td colspan="1" rowspan="1">Qureshi <xref rid="b0530" ref-type="bibr">[106]</xref></td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">RF; SVM; KNN; LDA; CART</td><td colspan="1" rowspan="1">201</td><td colspan="1" rowspan="1">Molecular structure and somatic mutations of EGFR</td><td colspan="1" rowspan="1">Accuracy (0.975)</td><td colspan="1" rowspan="1">10-fold cross-validation</td><td colspan="1" rowspan="1">4 clinical features&#160;+&#160;4 protein drug interaction features&#160;+&#160;5 geometrical features</td><td colspan="1" rowspan="1">The model integrates multiple features for data training, and achieves better performance than other benchmarked models</td><td colspan="1" rowspan="1">Among the possible 594 EGFR mutations available in the COSMIC database, the model only considers the most common 33 EGFR mutations for model training</td></tr><tr><td colspan="1" rowspan="1">Kapil et al. <xref rid="b0535" ref-type="bibr">[107]</xref></td><td colspan="1" rowspan="1">AC-GAN</td><td colspan="1" rowspan="1">AC-GAN</td><td colspan="1" rowspan="1">270</td><td colspan="1" rowspan="1">Digital pathology images</td><td colspan="1" rowspan="1">Lcc (0.94); Pcc (0.95); MAE (8.03)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">PD-L1-stained tumor section histological slides</td><td colspan="1" rowspan="1">The model achieves better performance than other benchmarked, fully supervised models</td><td colspan="1" rowspan="1">In the experiments, the use of PD-L1 staining for TPS evaluation may not be accurate enough</td></tr><tr><td colspan="1" rowspan="1">Geeleher et al. <xref rid="b0545" ref-type="bibr">[109]</xref></td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">Ridge regression model</td><td colspan="1" rowspan="1">62</td><td colspan="1" rowspan="1">RNA-seq</td><td colspan="1" rowspan="1">Accuracy (0.89)</td><td colspan="1" rowspan="1">Leave-one-out cross-validation</td><td colspan="1" rowspan="1">Removed low variable genes</td><td colspan="1" rowspan="1">The model can accurately predict the drug response using RNA-seq profiles only</td><td colspan="1" rowspan="1">The training sample size is small</td></tr><tr><td colspan="1" rowspan="1">Chen et al. <xref rid="b0615" ref-type="bibr">[123]</xref></td><td colspan="1" rowspan="1">Chi-square test&#160;+&#160;NN</td><td colspan="1" rowspan="1">NN</td><td colspan="1" rowspan="1">440</td><td colspan="1" rowspan="1">RNA-seq</td><td colspan="1" rowspan="1">Accuracy (0.83)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">RNA-seq of 5 genes</td><td colspan="1" rowspan="1">The model uses multiple laboratory datasets for training to improve its robustness</td><td colspan="1" rowspan="1">The model doesn&#8217;t consider demographic and clinical features, which may affect the prediction</td></tr><tr><td colspan="1" rowspan="1">LUADpp <xref rid="b0625" ref-type="bibr">[125]</xref></td><td colspan="1" rowspan="1">Top genes with most significant mutation frequency difference</td><td colspan="1" rowspan="1">SVM</td><td colspan="1" rowspan="1">371</td><td colspan="1" rowspan="1">Somatic mutations</td><td colspan="1" rowspan="1">Accuracy (0.81)</td><td colspan="1" rowspan="1">5-fold cross-validation</td><td colspan="1" rowspan="1">Somatic mutation features in 85 genes</td><td colspan="1" rowspan="1">The model can predict with high accuracy with only seven gene mutation features</td><td colspan="1" rowspan="1">Mutation frequency may be impacted by the sampling bias across datasets;<break/>LD may also affect the feature selection</td></tr><tr><td colspan="1" rowspan="1">Cho et al. <xref rid="b0630" ref-type="bibr">[126]</xref></td><td colspan="1" rowspan="1">Information gain; Chi-squared test; minimum redundancy maximum relevance; correlation algorithm</td><td colspan="1" rowspan="1">NB; KNN; SVM; DT</td><td colspan="1" rowspan="1">471</td><td colspan="1" rowspan="1">Somatic mutations</td><td colspan="1" rowspan="1">Accuracy (0.68&#8211;0.88)</td><td colspan="1" rowspan="1">5-fold cross-validation</td><td colspan="1" rowspan="1">Somatic mutation features composed of 19 genes</td><td colspan="1" rowspan="1">To improve performance, the model uses four different methods for feature selection</td><td colspan="1" rowspan="1">The training cohort consists of only one dataset</td></tr><tr><td colspan="1" rowspan="1">Yu et al. <xref rid="b0640" ref-type="bibr">[128]</xref></td><td colspan="1" rowspan="1">Information gain ratio; hierarchical clustering</td><td colspan="1" rowspan="1">RF</td><td colspan="1" rowspan="1">538</td><td colspan="1" rowspan="1">Multi-omics (histology, pathology reports, RNA, proteomics)</td><td colspan="1" rowspan="1">AUC (&gt; 0.8)</td><td colspan="1" rowspan="1">leave-one-out cross-validation</td><td colspan="1" rowspan="1">15 gene set features</td><td colspan="1" rowspan="1">The study uses an integrative omics-pathology model to improve the accuracy in predicting patients&#8217; prognosis</td><td colspan="1" rowspan="1">Cox models may be overfitted in multiple-dimension data</td></tr><tr><td colspan="1" rowspan="1">Asada et al. <xref rid="b0650" ref-type="bibr">[130]</xref></td><td colspan="1" rowspan="1">Autoencoder&#160;+&#160;<break/>Cox-PH&#160;+&#160;K-means&#160;+&#160;<break/>ANOVA</td><td colspan="1" rowspan="1">SVM</td><td colspan="1" rowspan="1">364</td><td colspan="1" rowspan="1">Multi-omics (miRNA, mRNA)</td><td colspan="1" rowspan="1">Accuracy (0.81)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">20 miRNAs&#160;+&#160;25 mRNAs</td><td colspan="1" rowspan="1">The study uses ML algorithms to systematically model feature extraction from multi-omics datasets</td><td colspan="1" rowspan="1">The model does not consider the impact of clinical and demographic variances in data training</td></tr><tr><td colspan="1" rowspan="1">Takahashi et al. <xref rid="b0655" ref-type="bibr">[131]</xref></td><td colspan="1" rowspan="1">Autoencoder&#160;+&#160;<break/>Cox-PH&#160;+&#160;K-means&#160;+&#160;<break/>XGBoost/LightGBM</td><td colspan="1" rowspan="1">LR</td><td colspan="1" rowspan="1">483</td><td colspan="1" rowspan="1">Multi-omics (mRNA, somatic mutation, CNV, mythelation, RPPA)</td><td colspan="1" rowspan="1">AUC (0.43&#8211;0.99 under different omics data)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">12 mRNAs, 3 miRNAs, 3 methylations,<break/>5 CNVs, 3 somatic mutations, and 3 RPPA</td><td colspan="1" rowspan="1">The study uses ML algorithms to systematically model feature extraction from multi-omics datasets</td><td colspan="1" rowspan="1">The datasets collected in this study contain uncommon samples between different omics datasets, which may cause bias in model evaluation</td></tr><tr><td colspan="1" rowspan="1">Wiesweg et al. <xref rid="b0680" ref-type="bibr">[136]</xref></td><td colspan="1" rowspan="1">Lasso regression</td><td colspan="1" rowspan="1">SVM</td><td colspan="1" rowspan="1">122</td><td colspan="1" rowspan="1">RNA-seq</td><td colspan="1" rowspan="1">Significant hazard ratio differences</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">7 genes from feature selection model&#160;+&#160;<break/>25 cell type-specific genes</td><td colspan="1" rowspan="1">The ML-based feature extraction model performs better than using any single immune marker for immunotherapy response prediction</td><td colspan="1" rowspan="1">The metrics used in this study does not perceptual intuition. Using accuracy or AUC may be better</td></tr><tr><td colspan="1" rowspan="1">Trebeschi et al. <xref rid="b0685" ref-type="bibr">[137]</xref></td><td colspan="1" rowspan="1">LR; RF</td><td colspan="1" rowspan="1">LR; RF</td><td colspan="1" rowspan="1">262</td><td colspan="1" rowspan="1">CT imaging</td><td colspan="1" rowspan="1">AUC (0.76&#8211;0.83)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">10 radiographic features</td><td colspan="1" rowspan="1">The model can extract potential predictive CT-derived radiomic biomarkers to improve immunotherapy response prediction</td><td colspan="1" rowspan="1">The predictive performance between different cancer types is not robust</td></tr><tr><td colspan="1" rowspan="1">Saltz et al. <xref rid="b0710" ref-type="bibr">[142]</xref></td><td colspan="1" rowspan="1">CAE <xref rid="b0715" ref-type="bibr">[143]</xref></td><td colspan="1" rowspan="1">VGG16 <xref rid="b0720" ref-type="bibr">[144]</xref>&#160;+&#160;DeconvNet <xref rid="b0725" ref-type="bibr">[145]</xref></td><td colspan="1" rowspan="1">4612<break/>(13 cancer types)</td><td colspan="1" rowspan="1">Histological images</td><td colspan="1" rowspan="1">AUC (0.9544)</td><td colspan="1" rowspan="1">Hold-out</td><td colspan="1" rowspan="1">Image features of H&amp;E-stained tumor section histological slides</td><td colspan="1" rowspan="1">The model outperforms pathologists and other benchmarked models</td><td colspan="1" rowspan="1">The predictive performance between different cancer types is not robust</td></tr></tbody></table><table-wrap-foot><fn><p><italic toggle="yes">Note</italic>: MRRN, resolution residually connected network; CART, classification and regression trees; AC-GAN, auxiliary classifier generative adversarial networks; Lcc, Lin&#8217;s concordance coefficient; Pcc, Pearson correlation coefficient; MAE, mean absolute error; TPS, tumor proportional scoring; LD, linkage disequilibrium; Cox-PH, Cox proportional-hazards; ANOVA, analysis of variance; miRNA, microRNA; RPPA, reverse phase protein array; CAE, convolutional autoencoder; mRNA, messenger RNA; PD-L1, programmed cell death 1 ligand 1; COSMIC, the Catalogue Of Somatic Mutations In Cancer; EGFR, epidermal growth factor receptor. Compared with hold-out, cross-validation is usually more robust, and accounts for more variance between possible splits in training, validation, and test data. However, cross-validation is more time consuming than using the simple holdout method.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s0035"><title>Survival prediction</title><p id="p0040">Prognosis and survival prediction as a part of clinical oncology is a tough but essential task for physicians, as knowing the survival period can inform treatment decisions and benefit patients in managing costs <xref rid="b0560" ref-type="bibr">[112]</xref>, <xref rid="b0565" ref-type="bibr">[113]</xref>, <xref rid="b0570" ref-type="bibr">[114]</xref>. For most of the medical history, predictions relied primarily on the physician&#8217;s knowledge and experience based on prior patient histories and medical records. However, studies have indicated that physicians tend to execute poorly in predicting the prognosis and survival expectancy, often over-predicting survival time <xref rid="b0575" ref-type="bibr">[115]</xref>, <xref rid="b0580" ref-type="bibr">[116]</xref>, <xref rid="b0585" ref-type="bibr">[117]</xref>. Statistical algorithms, such as the Cox proportional-hazards model <xref rid="b0590" ref-type="bibr">[118]</xref>, have been implemented to assist physicians&#8217; prediction in many studies <xref rid="b0595" ref-type="bibr">[119]</xref>, <xref rid="b0600" ref-type="bibr">[120]</xref>, <xref rid="b0605" ref-type="bibr">[121]</xref>, <xref rid="b0610" ref-type="bibr">[122]</xref>, but they are not particularly accurate <xref rid="b0060" ref-type="bibr">[12]</xref>. As a comparison, ML has shown its potential to predict a patient&#8217;s prognosis and survival in genomic, transcriptomic, proteomic, radiomic, and other datasets (<xref rid="f0020" ref-type="fig">Figure 4</xref>; <xref rid="t0015" ref-type="table">Table 3</xref>). Chen et al. <xref rid="b0615" ref-type="bibr">[123]</xref> used 3-year survival as a threshold to split the patients into high-risk (survival time&#160;&lt;&#160;36&#160;months) and low-risk (survival time&#160;&gt;&#160;36&#160;months) groups, and then constructed a NN model to binary predict the risk of a patient using his gene expression data and clinical variables. In their model, they tested four microarray gene expression datasets and achieved an overall accuracy of 83.0% with only five identified genes correlated with survival time. Liu et al. <xref rid="b0620" ref-type="bibr">[124]</xref> also utilized gene expression data for a 3-year survival classification. Unlike Chen et al. <xref rid="b0615" ref-type="bibr">[123]</xref>, the authors integrated three types of sequencing data &#8212; RNA sequencing, DNA methylation, and DNA mutation &#8212; to select a total of 22 genes to improve their model&#8217;s stability. Meanwhile, LUADpp <xref rid="b0625" ref-type="bibr">[125]</xref> and Cho et al. <xref rid="b0630" ref-type="bibr">[126]</xref> used the somatic mutations as input features to model a 3-year survival risk classification. To select the genes associated with the highest significant mortality, Cho et al. <xref rid="b0630" ref-type="bibr">[126]</xref> used chi-squared tests, and LUADpp <xref rid="b0625" ref-type="bibr">[125]</xref> used a published genome-wide rate comparison test <xref rid="b0635" ref-type="bibr">[127]</xref> that was able to balance statistical power and precision to compare gene mutation rates. Due to the complexity of survival prediction, multi-omics tumor data have been integrated for analysis in many studies. Compared with single-omics data, the multi-omics data are more challenging to accurately extract the most significant genes for prediction. To address the issue, several studies <xref rid="b0640" ref-type="bibr">[128]</xref>, <xref rid="b0645" ref-type="bibr">[129]</xref>, <xref rid="b0650" ref-type="bibr">[130]</xref>, <xref rid="b0655" ref-type="bibr">[131]</xref> designed a similar workflow. They first constructed a matrix representing the similarity between patients based on their multi-omics data. Using the obtained matrix, they then employed an unsupervised clustering model (usually autoencoder with K-means clustering) to categorize the patients into two clusters. The two clusters were labeled &#8220;high-risk&#8221; and &#8220;low-risk&#8221; in terms of the different survival outcomes between the two clusters in the Kaplan&#8211;Meier analysis. Following the survival outcome differences, the genes associated with mortality were extracted using a statistical model <xref rid="b0640" ref-type="bibr">[128]</xref>, <xref rid="b0645" ref-type="bibr">[129]</xref> or an ML model <xref rid="b0650" ref-type="bibr">[130]</xref>, <xref rid="b0655" ref-type="bibr">[131]</xref> for downstream analyses.</p></sec></sec><sec id="s0040"><title>Apply ML to lung cancer immunotherapy</title><sec id="s0045"><title>Immunotherapy response prediction</title><p id="p0045">Immunotherapy has become increasingly important in recent years. It enables a patient&#8217;s own immune system to fight cancer, in most cases, by stimulating T cells. Up to date, distinct novel immunotherapy treatments are being tested for lung cancer, and a variety of them have become standard parts of immunotherapy. Immune checkpoint inhibitors (ICIs), especially programmed cell death protein 1 (PD&#8208;1)/programmed cell death protein ligand 1 (PD&#8208;L1) blockade therapy <xref rid="b0660" ref-type="bibr">[132]</xref>, have been demonstrated to be valuable in the treatment of patients with non-small cell lung cancer (NSCLC) <xref rid="b0665" ref-type="bibr">[133]</xref>, <xref rid="b0670" ref-type="bibr">[134]</xref>. However, immunotherapy is not yet as widely used as surgery, chemotherapy, or radiation therapies. One interpretation is that it does not work for all patients due to the uniqueness of a patient&#8217;s tumor immune microenvironment (TIME). Therefore, estimating whether a patient will respond to immunotherapy is important for cancer treatment. Recently, AI-based technologies have been developed to predict immunotherapy responses based on immune sequencing signatures and medical imaging signatures (<xref rid="f0020" ref-type="fig">Figure 4</xref>; <xref rid="t0015" ref-type="table">Table 3</xref>) <xref rid="b0675" ref-type="bibr">[135]</xref>. To predict the response to PD-1/PD-L1 blockade therapy, Wiesweg et al. <xref rid="b0680" ref-type="bibr">[136]</xref> utilized gene expression profiles of 7 significant genes extracted from ML models plus 25 cell type-specific genes as input features to train an SVM classifier for RECIST classification. Aside from sequencing data, features from CT scans can also be used to assess the RECIST level of a patient. Two recent studies <xref rid="b0685" ref-type="bibr">[137]</xref>, <xref rid="b0690" ref-type="bibr">[138]</xref> used radiomic biomarkers as well as other imaging features of tumor lesions from contrast-enhanced computed tomography (CE-CT) scans to train a classifier, including LR and RF, for RECIST classification.</p></sec><sec id="s0050"><title>Tumor-infiltrating lymphocyte evaluation</title><p id="p0050">The proportion of tumor-infiltrating lymphocytes (TILs) is another important metric for immunotherapy response evaluation. To this end, using transcriptomics data, DeepTIL <xref rid="b0695" ref-type="bibr">[139]</xref> optimized the cell deconvolution model CIBERSORT <xref rid="b0700" ref-type="bibr">[140]</xref> to automatically compute the abundance of the leucocyte subsets (B cells, CD4<sup>+</sup> T cells, CD8<sup>+</sup> T cells, &#947;&#948; T cells, Mo-Ma-DC cells, and granulocytes) within a tumor sample. A different approach <xref rid="b0705" ref-type="bibr">[141]</xref> utilized a total of 84 radiomic features from the CE-CT scans, along with RNA sequencing of 20,530 genes as biomarkers to train a linear elastic-net regression model to predict the abundance of CD8<sup>+</sup> T cells. Another study <xref rid="b0710" ref-type="bibr">[142]</xref> created a DL model to identify TILs in digitized H&amp;E-stained images (<xref rid="t0015" ref-type="table">Table 3</xref>). The methodology consisted of two unique CNN modules to evaluate TILs at different scales: a lymphocyte infiltration classification CNN (lymphocyte CNN) and a necrosis segmentation CNN (necrosis CNN). The &#8220;lymphocyte CNN&#8221; aimed to categorize the input image into with- and without-lymphocyte infiltration regions. It consists of two steps: a convolutional autoencoder (CAE) <xref rid="b0715" ref-type="bibr">[143]</xref> for feature extraction, followed by a VGG 16-layer network <xref rid="b0720" ref-type="bibr">[144]</xref> for TIL region classification. The &#8220;necrosis CNN&#8221; aimed to detect TILs within a necrosis region. They used the DeconvNet <xref rid="b0725" ref-type="bibr">[145]</xref> model for TIL segmentation in &#8220;necrosis CNN&#8221; as the model has been shown to achieve high accuracy with several benchmark imaging datasets.</p></sec><sec id="s0055"><title>Neoantigen prediction</title><p id="p0055">In addition to immunotherapy response prediction, ML algorithms have shed light on neoantigen prediction for immunotherapy. Neoantigens are tumor-specific mutated peptides generated by somatic mutations in tumor cells, which can induce antitumor immune responses <xref rid="b0730" ref-type="bibr">[146]</xref>, <xref rid="b0735" ref-type="bibr">[147]</xref>, <xref rid="b0740" ref-type="bibr">[148]</xref>. Recent work has demonstrated that immunogenic neoantigens are benefit to the development and optimization of neoantigen-targeted immune therapies <xref rid="b0745" ref-type="bibr">[149]</xref>, <xref rid="b0750" ref-type="bibr">[150]</xref>, <xref rid="b0755" ref-type="bibr">[151]</xref>, <xref rid="b0760" ref-type="bibr">[152]</xref>. In accordance with neoantigen studies in clinical trials, state-of-the-art ML approaches have been implemented to identify neoantigens based on human leukocyte antigen (HLA) class I and II processing and presentation <xref rid="b0765" ref-type="bibr">[153]</xref>, <xref rid="b0770" ref-type="bibr">[154]</xref>, <xref rid="b0775" ref-type="bibr">[155]</xref>, <xref rid="b0780" ref-type="bibr">[156]</xref>, <xref rid="b0785" ref-type="bibr">[157]</xref>. Using the identified somatic mutations, ML models can estimate the binding affinity of the encoded mutated peptides to the patient&#8217;s HLA alleles (peptide&#8211;HLA binding affinity). The neoantigens can be further predicted based on the estimated peptide&#8211;HLA binding affinity. NetMHC <xref rid="b0790" ref-type="bibr">[158]</xref>, <xref rid="b0795" ref-type="bibr">[159]</xref> utilized a receptor&#8211;ligand dataset consisting of 528 peptide&#8211;HLA binding interactions measured by Buus et al. <xref rid="b0800" ref-type="bibr">[160]</xref> to train a combination of several NNs for neo-peptide affinity prediction. To make the prediction more accurate, NetMHCpan <xref rid="b0805" ref-type="bibr">[161]</xref>, <xref rid="b0810" ref-type="bibr">[162]</xref> used a larger dataset consisting of 37,384 unique peptide&#8211;HLA interactions covering 24 HLA-A alleles and 18 HLA-B alleles (26,503 and 10,881 for the A and B alleles, respectively) to train their NN model. Both tools have been implemented to study the neoantigen landscape in lung cancers <xref rid="b0730" ref-type="bibr">[146]</xref>, <xref rid="b0815" ref-type="bibr">[163]</xref>, <xref rid="b0820" ref-type="bibr">[164]</xref>, <xref rid="b0825" ref-type="bibr">[165]</xref>.</p></sec></sec><sec id="s0060"><title>Challenges and future perspectives</title><p id="p0060">Despite the widespread use of ML studies in lung cancer clinical practice and research, there are still challenges to be addressed. Here, we post some examples of recent ML algorithms, especially the increasingly popular and important DL algorithms of the past decade, to enlighten them on lung cancer therapy analyses, as well as the challenges for future lung cancer studies.</p><sec id="s0065"><title>Imaging data analysis</title><p id="p0065">Learning how to effectively extract nuance from imaging data is critical for clinical use. In the earlier ML-based CAD system, feature extractions were typically based on the image intensity, shape, and texture of a suspicious region along with other clinical variables <xref rid="b0830" ref-type="bibr">[166]</xref>. However, these approaches are arbitrarily defined and may not retrieve the intrinsic features of a suspicious nodule. To this end, a DL-based CAD system was developed leveraging CNN models to extract features directly from raw imaging data with multilevel representations and hierarchical abstraction <xref rid="b0835" ref-type="bibr">[167]</xref>, <xref rid="b0840" ref-type="bibr">[168]</xref>, <xref rid="b0845" ref-type="bibr">[169]</xref>. Contrary to previous methods, features from a CNN model are not designed by humans, and reflect the intrinsic features of the nodule in an objective and comprehensive manner. Recently, the Vision Transformer (ViT) has emerged as the current state-of-the-art in computer vision <xref rid="b0850" ref-type="bibr">[170]</xref>, <xref rid="b0855" ref-type="bibr">[171]</xref>. In comparison to CNN, ViT outperformed almost 4&#215; in terms of computational efficiency and accuracy, and was more robust when training on smaller datasets <xref rid="b0860" ref-type="bibr">[172]</xref>. Although, to our knowledge, ViT models have not been implemented in any lung cancer imaging studies, they have shown their potential as a competitive alternative to CNN in imaging data analysis.</p></sec><sec id="s0070"><title>Omics dataset analysis</title><p id="p0070">DL is a subfield of ML, which uses programmable NNs to make accurate decisions. It particularly shines when it comes to complex problems such as image classification. In this study, we reviewed the utility of DL models in imaging datasets. Compared with imaging datasets, DL algorithms were less frequent in lung cancer clinical studies using omics data. However, DL models have been extensively applied in other fields of omics analysis. For example, the genomics data are continuous sequences, thus recurrent neural network (RNN) models <xref rid="b0865" ref-type="bibr">[173]</xref> and CNN models <xref rid="b0870" ref-type="bibr">[174]</xref> are good tools for the population genetics analysis. Moreover, considering the input dimension of the omics data is usually very high, to improve efficiency and reduce overfitting, many studies have used autoencoders or deep generative models for feature extraction and dimensionality reduction <xref rid="b0875" ref-type="bibr">[175]</xref>. In the meantime, self-supervised representation learning models can overcome the curse of dimensionality and integrate multi-omics data to combine information about different aspects of the same tissue samples <xref rid="b0880" ref-type="bibr">[176]</xref>. Accompanied by the development of single-cell-based <xref rid="b0885" ref-type="bibr">[177]</xref> and spatial-based <xref rid="b0890" ref-type="bibr">[178]</xref> technologies that have been applied in molecular studies, numerous DL models are becoming more popular for computationally intensive analysis. To deal with the complexity of large genomics data, unsupervised deep clustering tools have been built for population structure identification <xref rid="b0895" ref-type="bibr">[179]</xref> or cell population subtype annotation <xref rid="b0900" ref-type="bibr">[180]</xref>, <xref rid="b0905" ref-type="bibr">[181]</xref>, <xref rid="b0910" ref-type="bibr">[182]</xref>, <xref rid="b0915" ref-type="bibr">[183]</xref>. In addition, to process the complex structure of multi-omics data, graph neural network (GNN) models are increasingly popular in dataset integration <xref rid="b0920" ref-type="bibr">[184]</xref>, biomedical classification <xref rid="b0925" ref-type="bibr">[185]</xref>, prognosis prediction <xref rid="b0930" ref-type="bibr">[186]</xref>, and so on. Though these studies have not been directly applied to lung cancer clinical analysis, they are a good inspiration for using DL tools to address complex lung cancer omics datasets.</p></sec><sec id="s0075"><title>Multi-view data and multi-database integration</title><p id="p0075">It is common to access large amounts of imaging data, multi-omics data, and clinical records from a single patient nowadays. Integrating these data provides a comprehensive insight into the molecular functions of lung cancer studies. However, these data types are typically obtained from different platforms, so platform noise inevitably exists between these data types. For example, imaging data analysis, especially radiomics, usually comes with the challenges of complicated data normalization, data fusion, and data integration. To overcome this limitation, multimodality medical segmentation networks have been developed to jointly process multimodality medical images <xref rid="b0935" ref-type="bibr">[187]</xref>. Similarly, for sequencing data types, batch noise also exists between different databases (<italic toggle="yes">i.e.</italic>, batch effect). Removing batch effects and integrating datasets from multiple platforms together in a framework that allows us to further analyze the mechanisms of cancer drug resistance and recurrence is important for cancer therapies. Though biomedical studies have experimented and/or benchmarked integrative tools <xref rid="b0940" ref-type="bibr">[188]</xref>, <xref rid="b0945" ref-type="bibr">[189]</xref>, <xref rid="b0950" ref-type="bibr">[190]</xref>, <xref rid="b0955" ref-type="bibr">[191]</xref>, they are not comprehensive and discriminating enough to address the choice of tools in the context of biological questions of interest.</p></sec><sec id="s0080"><title>Model generalizability and robustness</title><p id="p0080">In terms of this review, we find that the performance of an ML algorithm usually varies across different datasets. One interpretation might be the existence of a database batch effect that we discussed earlier. However, the absence of generalizability and robustness might be other factors that hurdle these ML models in clinical studies. In addition, to reduce overfitting, most studies used either statistical models or ML models to select marker genes before classification. However, these marker genes are usually quite different between studies, indicating that the identified marker genes lack generalizability and biological interpretability. To improve the generalizability and robustness of a model, it is important to develop a better understanding of robustness issues in different ML architectures and bridge the gap in robustness techniques among different domains. For example, recent studies have applied transfer learning to use a pre-trained model when training their own datasets in lung cancer imaging data analysis <xref rid="b0190" ref-type="bibr">[38]</xref>, <xref rid="b0275" ref-type="bibr">[55]</xref>, <xref rid="b0960" ref-type="bibr">[192]</xref>, and have improved the efficiency and robustness of their CNN-based models. For sequencing datasets, transfer learning has also been used in deep NNs to provide a generalizability approach <xref rid="b0965" ref-type="bibr">[193]</xref>, which could be a good example of building a general and robust model for lung cancer sequencing data analysis. In addition, DL is a complex black-box model. Understanding the mechanisms of a DL system in clinical studies could help to build a standardized and unified DL framework to improve its performance and robustness. The explainable AI (XAI) models have provided a tool for model-specific and model-agnostic analysis <xref rid="b0970" ref-type="bibr">[194]</xref>, <xref rid="b0975" ref-type="bibr">[195]</xref>. These methods can provide the explanations of a model at local and global levels, which further helps the researchers to fine-tune hyper-parameters from different models with high efficacy <xref rid="b0980" ref-type="bibr">[196]</xref>, <xref rid="b0985" ref-type="bibr">[197]</xref>.</p></sec><sec id="s0085"><title>Metrics for performance evaluation</title><p id="p0085">Studies usually focus on the development of algorithms for clinical studies. However, metrics selection for performance assessment of these algorithms is usually neglected, though it usually plays an important component in ML systems <xref rid="b0990" ref-type="bibr">[198]</xref>. Based on this review (<xref rid="t0005" ref-type="table">Table 1</xref>, <xref rid="t0010" ref-type="table">Table 2</xref>, <xref rid="t0015" ref-type="table">Table 3</xref>), accuracy and under the curve (AUC) are the two most conventional metrics, whereas these metrics do not always reflect the clinical needs and should be translated into clinically explainable metrics. Compared with accuracy, sensitivity or specificity might be more associated with clinical needs under certain circumstances, for example, patients at high risk of emergency department visits <xref rid="b0995" ref-type="bibr">[199]</xref>.</p></sec><sec id="s0090"><title>Clinical decision-making</title><p id="p0090">A recent study estimated that the overall costs for lung cancer therapy would exceed $50,000 <xref rid="b1000" ref-type="bibr">[200]</xref> for most patients, and that the cost would be high for most families. Thus, accurate prognosis prediction and decision-making will pave the way for personalized treatment. Recent DL models have been used to predict the effectiveness of a therapy/drug and optimize the combination of different therapies/drugs <xref rid="b1005" ref-type="bibr">[201]</xref>, <xref rid="b1010" ref-type="bibr">[202]</xref>. However, most existing DL models for clinical decision-making have difficulty in keeping up with knowledge evolution and/or dynamic health care data change <xref rid="b1015" ref-type="bibr">[203]</xref>. Currently, clinical decision support systems, including IBM Watson Health and Google DeepMind Health, have been implemented in lung cancer treatments in recent years <xref rid="b1020" ref-type="bibr">[204]</xref>, <xref rid="b1025" ref-type="bibr">[205]</xref>. Although the efficiency of clinical work has improved with the help of these systems, they are still far from perfect in terms of clinical trials, and currently cannot replace physicians at this stage <xref rid="b1025" ref-type="bibr">[205]</xref>.</p></sec></sec><sec id="s0095"><title>Conclusion</title><p id="p0095">AI grants us a different perspective on lung cancer research and allows for exploring the implementation of decision support tools to facilitate precision oncology. In this review, we surveyed the current advances of ML algorithms in various areas of lung cancer therapy, including early detection, diagnosis decision, prognosis prediction, drug response evaluation, and immunotherapy practice. To aid future ML development in lung cancer therapies, we thoroughly summarized the datasets (Table S1), baseline methods (Table S2), and characteristics of the methods (<xref rid="t0005" ref-type="table">Table 1</xref>, <xref rid="t0010" ref-type="table">Table 2</xref>, <xref rid="t0015" ref-type="table">Table 3</xref>). At last, we highlighted the current challenges that need to be addressed, such as the current lack of quantity and quality of medical data labels for training, the importance of model robustness and biomedical explanations for clinical use, the concern of the metrics used for performance evaluation, and the need for data integration and batch removal. As this review indicates, future lung cancer therapies will include both imaging data and omics data, so an ML clinical decision-making tool should be a multi-modal system that considers both imaging data and omics data treatment, and the integration of multiple data types. Finally, we expect that these challenges could motivate further studies to focus on lung cancer therapies.</p></sec><sec id="s0105"><title>CRediT author statement</title><p id="p0105"><bold>Yawei Li:</bold> Conceptualization, Data curation, Writing - original draft, Visualization. <bold>Xin Wu:</bold> Data curation, Writing - original draft, Visualization. <bold>Ping Yang:</bold> Writing - review &amp; editing. <bold>Guoqian Jiang:</bold> Writing - review &amp; editing. <bold>Yuan Luo:</bold> Conceptualization, Funding acquisition, Writing - review &amp; editing. All authors have read and approved the final manuscript.</p></sec><sec sec-type="COI-statement" id="s0100"><title>Competing interests</title><p id="p0100">The authors have declared no competing interests.</p></sec></body><back><ref-list id="bi005"><title>References</title><ref id="b0005"><label>1</label><element-citation publication-type="journal" id="h0005"><person-group person-group-type="author"><name name-style="western"><surname>Thai</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Solomon</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Sequist</surname><given-names>L.V.</given-names></name><name name-style="western"><surname>Gainor</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Heist</surname><given-names>R.S.</given-names></name></person-group><article-title>Lung cancer</article-title><source>Lancet</source><volume>398</volume><year>2021</year><fpage>535</fpage><lpage>554</lpage><pub-id pub-id-type="pmid">34273294</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(21)00312-3</pub-id></element-citation></ref><ref id="b0010"><label>2</label><element-citation publication-type="journal" id="h0010"><person-group person-group-type="author"><name name-style="western"><surname>Svoboda</surname><given-names>E.</given-names></name></person-group><article-title>Artificial intelligence is improving the detection of lung cancer</article-title><source>Nature</source><volume>587</volume><year>2020</year><fpage>S20</fpage><lpage>S22</lpage><pub-id pub-id-type="pmid">33208974</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/d41586-020-03157-9</pub-id></element-citation></ref><ref id="b0015"><label>3</label><element-citation publication-type="journal" id="h0015"><person-group person-group-type="author"><name name-style="western"><surname>Ling</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Extremely high genetic diversity in a single tumor points to prevalence of non-darwinian cell evolution</article-title><source>Proc Natl Acad Sci U S A</source><volume>112</volume><year>2015</year><fpage>E6496</fpage><lpage>E6505</lpage><pub-id pub-id-type="pmid">26561581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1519556112</pub-id><pub-id pub-id-type="pmcid">PMC4664355</pub-id></element-citation></ref><ref id="b0020"><label>4</label><element-citation publication-type="journal" id="h0020"><person-group person-group-type="author"><name name-style="western"><surname>International Cancer Genome Consortium</surname></name><name name-style="western"><surname>Hudson</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>W.</given-names></name><name name-style="western"><surname>Artez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Barker</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Bell</surname><given-names>C.</given-names></name><etal/></person-group><article-title>International network of cancer genome projects</article-title><source>Nature</source><volume>464</volume><year>2010</year><fpage>993</fpage><lpage>998</lpage><pub-id pub-id-type="pmid">20393554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature08987</pub-id><pub-id pub-id-type="pmcid">PMC2902243</pub-id></element-citation></ref><ref id="b0025"><label>5</label><element-citation publication-type="journal" id="h0025"><person-group person-group-type="author"><name name-style="western"><surname>Cancer Genome Atlas Research Network</surname></name><name name-style="western"><surname>Weinstein</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Collisson</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Mills</surname><given-names>G.B.</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>Ozenberger</surname><given-names>B.A.</given-names></name><etal/></person-group><article-title>The Cancer Genome Atlas Pan-Cancer analysis project</article-title><source>Nat Genet</source><volume>45</volume><year>2013</year><fpage>1113</fpage><lpage>1120</lpage><pub-id pub-id-type="pmid">24071849</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ng.2764</pub-id><pub-id pub-id-type="pmcid">PMC3919969</pub-id></element-citation></ref><ref id="b0030"><label>6</label><element-citation publication-type="journal" id="h0030"><person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>K.</given-names></name><name name-style="western"><surname>Vendt</surname><given-names>B.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>K.</given-names></name><name name-style="western"><surname>Freymann</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kirby</surname><given-names>J.</given-names></name><name name-style="western"><surname>Koppel</surname><given-names>P.</given-names></name><etal/></person-group><article-title>The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository</article-title><source>J Digit Imaging</source><volume>26</volume><year>2013</year><fpage>1045</fpage><lpage>1057</lpage><pub-id pub-id-type="pmid">23884657</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10278-013-9622-7</pub-id><pub-id pub-id-type="pmcid">PMC3824915</pub-id></element-citation></ref><ref id="b0035"><label>7</label><element-citation publication-type="journal" id="h0035"><person-group person-group-type="author"><name name-style="western"><surname>Pavlopoulou</surname><given-names>A.</given-names></name><name name-style="western"><surname>Spandidos</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Michalopoulos</surname><given-names>I.</given-names></name></person-group><article-title>Human cancer databases (review)</article-title><source>Oncol Rep</source><volume>33</volume><year>2015</year><fpage>3</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">25369839</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/or.2014.3579</pub-id><pub-id pub-id-type="pmcid">PMC4254674</pub-id></element-citation></ref><ref id="b0040"><label>8</label><element-citation publication-type="journal" id="h0040"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Szolovits</surname><given-names>P.</given-names></name></person-group><article-title>Tensor factorization toward precision medicine</article-title><source>Brief Bioinform</source><volume>18</volume><year>2016</year><fpage>511</fpage><lpage>514</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bib/bbw026</pub-id><pub-id pub-id-type="pmcid">PMC6078180</pub-id><pub-id pub-id-type="pmid">26994614</pub-id></element-citation></ref><ref id="b0045"><label>9</label><element-citation publication-type="journal" id="h0045"><person-group person-group-type="author"><name name-style="western"><surname>Kolda</surname><given-names>T.G.</given-names></name><name name-style="western"><surname>Bader</surname><given-names>B.W.</given-names></name></person-group><article-title>Tensor decompositions and applications</article-title><source>SIAM Rev</source><volume>51</volume><year>2009</year><fpage>455</fpage><lpage>500</lpage></element-citation></ref><ref id="b0050"><label>10</label><element-citation publication-type="journal" id="h0050"><person-group person-group-type="author"><name name-style="western"><surname>Chao</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name></person-group><article-title>Supervised nonnegative matrix factorization to predict icu mortality risk</article-title><source>Proceedings (IEEE Int Conf Bioinformatics Biomed)</source><volume>2018</volume><year>2018</year><fpage>1189</fpage><lpage>1194</lpage><pub-id pub-id-type="pmid">31360595</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/BIBM.2018.8621403</pub-id><pub-id pub-id-type="pmcid">PMC6662568</pub-id></element-citation></ref><ref id="b0055"><label>11</label><element-citation publication-type="journal" id="h0055"><person-group person-group-type="author"><name name-style="western"><surname>Chi</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Kolda</surname><given-names>T.G.</given-names></name></person-group><article-title>On tensors, sparsity, and nonnegative factorizations</article-title><source>SIAM J Matrix Anal Appl</source><volume>33</volume><year>2012</year><fpage>1272</fpage><lpage>1299</lpage></element-citation></ref><ref id="b0060"><label>12</label><element-citation publication-type="journal" id="h0060"><person-group person-group-type="author"><name name-style="western"><surname>Tran</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Kondrashova</surname><given-names>O.</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>A.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>E.D.</given-names></name><name name-style="western"><surname>Pearson</surname><given-names>J.V.</given-names></name><name name-style="western"><surname>Waddell</surname><given-names>N.</given-names></name></person-group><article-title>Deep learning in cancer diagnosis, prognosis and treatment selection</article-title><source>Genome Med</source><volume>13</volume><year>2021</year><fpage>152</fpage><pub-id pub-id-type="pmid">34579788</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13073-021-00968-x</pub-id><pub-id pub-id-type="pmcid">PMC8477474</pub-id></element-citation></ref><ref id="b0065"><label>13</label><element-citation publication-type="journal" id="h0065"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Roy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Espino</surname><given-names>S.</given-names></name><name name-style="western"><surname>Clare</surname><given-names>S.E.</given-names></name><etal/></person-group><article-title>Identifying breast cancer distant recurrences from electronic health records using machine learning</article-title><source>J Healthc Inform Res</source><volume>3</volume><year>2019</year><fpage>283</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">33225204</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s41666-019-00046-3</pub-id><pub-id pub-id-type="pmcid">PMC7678240</pub-id></element-citation></ref><ref id="b0070"><label>14</label><element-citation publication-type="journal" id="h0070"><person-group person-group-type="author"><name name-style="western"><surname>Cruz</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Wishart</surname><given-names>D.S.</given-names></name></person-group><article-title>Applications of machine learning in cancer prediction and prognosis</article-title><source>Cancer Inform</source><volume>2</volume><year>2007</year><fpage>59</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">19458758</pub-id><pub-id pub-id-type="pmcid">PMC2675494</pub-id></element-citation></ref><ref id="b0075"><label>15</label><element-citation publication-type="journal" id="h0075"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name></person-group><article-title>Prediction of breast cancer distant recurrence using natural language processing and knowledge-guided convolutional neural network</article-title><source>Artif Intell Med</source><volume>110</volume><year>2020</year><object-id pub-id-type="publisher-id">101977</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.artmed.2020.101977</pub-id><pub-id pub-id-type="pmcid">PMC7983067</pub-id><pub-id pub-id-type="pmid">33250149</pub-id></element-citation></ref><ref id="b0080"><label>16</label><element-citation publication-type="journal" id="h0080"><person-group person-group-type="author"><name name-style="western"><surname>Cochran</surname><given-names>A.J.</given-names></name></person-group><article-title>Prediction of outcome for patients with cutaneous melanoma</article-title><source>Pigment Cell Res</source><volume>10</volume><year>1997</year><fpage>162</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">9266604</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0749.1997.tb00479.x</pub-id></element-citation></ref><ref id="b0085"><label>17</label><element-citation publication-type="journal" id="h0085"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Espino</surname><given-names>S.</given-names></name><name name-style="western"><surname>Roy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kitsch</surname><given-names>K.</given-names></name><name name-style="western"><surname>Clare</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Contralateral breast cancer event detection using natural language processing</article-title><source>AMIA Annu Symp Proc</source><volume>2017</volume><year>2018</year><fpage>1885</fpage><lpage>1892</lpage><pub-id pub-id-type="pmid">29854260</pub-id><pub-id pub-id-type="pmcid">PMC5977664</pub-id></element-citation></ref><ref id="b0090"><label>18</label><element-citation publication-type="journal" id="h0090"><person-group person-group-type="author"><name name-style="western"><surname>Kourou</surname><given-names>K.</given-names></name><name name-style="western"><surname>Exarchos</surname><given-names>T.P.</given-names></name><name name-style="western"><surname>Exarchos</surname><given-names>K.P.</given-names></name><name name-style="western"><surname>Karamouzis</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Fotiadis</surname><given-names>D.I.</given-names></name></person-group><article-title>Machine learning applications in cancer prognosis and prediction</article-title><source>Comput Struct Biotechnol J</source><volume>13</volume><year>2015</year><fpage>8</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">25750696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.csbj.2014.11.005</pub-id><pub-id pub-id-type="pmcid">PMC4348437</pub-id></element-citation></ref><ref id="b0095"><label>19</label><element-citation publication-type="journal" id="h0095"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hochberg</surname><given-names>E.</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Uzuner</surname><given-names>O.</given-names></name><name name-style="western"><surname>Szolovits</surname><given-names>P.</given-names></name></person-group><article-title>Subgraph augmented non-negative tensor factorization (SANTF) for modeling clinical narrative text</article-title><source>J Am Med Inform Assoc</source><volume>22</volume><year>2015</year><fpage>1009</fpage><lpage>1019</lpage><pub-id pub-id-type="pmid">25862765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jamia/ocv016</pub-id><pub-id pub-id-type="pmcid">PMC4986663</pub-id></element-citation></ref><ref id="b0100"><label>20</label><element-citation publication-type="journal" id="h0100"><person-group person-group-type="author"><name name-style="western"><surname>Benzekry</surname><given-names>S.</given-names></name></person-group><article-title>Artificial intelligence and mechanistic modeling for clinical decision making in oncology</article-title><source>Clin Pharmacol Ther</source><volume>108</volume><year>2020</year><fpage>471</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">32557598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cpt.1951</pub-id></element-citation></ref><ref id="b0105"><label>21</label><element-citation publication-type="journal" id="h0105"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name></person-group><article-title>Optimizing the evaluation of gene-targeted panels for tumor mutational burden estimation</article-title><source>Sci Rep</source><volume>11</volume><year>2021</year><fpage>21072</fpage><pub-id pub-id-type="pmid">34702927</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-021-00626-7</pub-id><pub-id pub-id-type="pmcid">PMC8548549</pub-id></element-citation></ref><ref id="b0110"><label>22</label><element-citation publication-type="journal" id="h0110"><person-group person-group-type="author"><name name-style="western"><surname>Bhinder</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gilvary</surname><given-names>C.</given-names></name><name name-style="western"><surname>Madhukar</surname><given-names>N.S.</given-names></name><name name-style="western"><surname>Elemento</surname><given-names>O.</given-names></name></person-group><article-title>Artificial intelligence in cancer research and precision medicine</article-title><source>Cancer Discov</source><volume>11</volume><year>2021</year><fpage>900</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">33811123</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/2159-8290.CD-21-0090</pub-id><pub-id pub-id-type="pmcid">PMC8034385</pub-id></element-citation></ref><ref id="b0115"><label>23</label><element-citation publication-type="journal" id="h0115"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Espino</surname><given-names>S.</given-names></name><name name-style="western"><surname>Roy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Clare</surname><given-names>S.E.</given-names></name><etal/></person-group><article-title>Using natural language processing and machine learning to identify breast cancer local recurrence</article-title><source>BMC Bioinformatics</source><volume>19</volume><year>2018</year><fpage>498</fpage><pub-id pub-id-type="pmid">30591037</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12859-018-2466-x</pub-id><pub-id pub-id-type="pmcid">PMC6309052</pub-id></element-citation></ref><ref id="b0120"><label>24</label><element-citation publication-type="journal" id="h0120"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sohani</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Hochberg</surname><given-names>E.P.</given-names></name><name name-style="western"><surname>Szolovits</surname><given-names>P.</given-names></name></person-group><article-title>Automatic lymphoma classification with sentence subgraph mining from pathology reports</article-title><source>J Am Med Inform Assoc</source><volume>21</volume><year>2014</year><fpage>824</fpage><lpage>832</lpage><pub-id pub-id-type="pmid">24431333</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/amiajnl-2013-002443</pub-id><pub-id pub-id-type="pmcid">PMC4147603</pub-id></element-citation></ref><ref id="b0125"><label>25</label><element-citation publication-type="journal" id="h0125"><person-group person-group-type="author"><name name-style="western"><surname>Luchini</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pea</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scarpa</surname><given-names>A.</given-names></name></person-group><article-title>Artificial intelligence in oncology: current applications and future perspectives</article-title><source>Br J Cancer</source><volume>126</volume><year>2022</year><fpage>4</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">34837074</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41416-021-01633-1</pub-id><pub-id pub-id-type="pmcid">PMC8727615</pub-id></element-citation></ref><ref id="b0130"><label>26</label><element-citation publication-type="journal" id="h0130"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Vo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Shidfar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Saldana</surname><given-names>P.</given-names></name><name name-style="western"><surname>Blanco</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer</article-title><source>NPJ Breast Cancer</source><volume>6</volume><year>2020</year><fpage>24</fpage><pub-id pub-id-type="pmid">32566745</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41523-020-0165-z</pub-id><pub-id pub-id-type="pmcid">PMC7293275</pub-id></element-citation></ref><ref id="b0135"><label>27</label><element-citation publication-type="journal" id="h0135"><person-group person-group-type="author"><name name-style="western"><surname>Na</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zong</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Midthun</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Characterizing phenotypic abnormalities associated with high-risk individuals developing lung cancer using electronic health records from the <italic toggle="yes">All of Us</italic> researcher workbench</article-title><source>J Am Med Inform Assoc</source><volume>28</volume><year>2021</year><fpage>2313</fpage><lpage>2324</lpage><pub-id pub-id-type="pmid">34505903</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jamia/ocab174</pub-id><pub-id pub-id-type="pmcid">PMC8510381</pub-id></element-citation></ref><ref id="b0140"><label>28</label><element-citation publication-type="journal" id="h0140"><person-group person-group-type="author"><name name-style="western"><surname>Fujita</surname><given-names>H.</given-names></name></person-group><article-title>AI-based computer-aided diagnosis (AI-CAD): the latest review to read first</article-title><source>Radiol Phys Technol</source><volume>13</volume><year>2020</year><fpage>6</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">31898014</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12194-019-00552-4</pub-id></element-citation></ref><ref id="b0145"><label>29</label><element-citation publication-type="journal" id="h0145"><person-group person-group-type="author"><name name-style="western"><surname>Yanase</surname><given-names>J.</given-names></name><name name-style="western"><surname>Triantaphyllou</surname><given-names>E.</given-names></name></person-group><article-title>A systematic survey of computer-aided diagnosis in medicine: past and present developments</article-title><source>Expert Syst Appl</source><volume>138</volume><year>2019</year><object-id pub-id-type="publisher-id">112821</object-id></element-citation></ref><ref id="b0150"><label>30</label><element-citation publication-type="journal" id="h0150"><person-group person-group-type="author"><name name-style="western"><surname>Abe</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hanai</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nakano</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ohkubo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hasizume</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kakizaki</surname><given-names>T.</given-names></name><etal/></person-group><article-title>A computer-aided diagnosis (CAD) system in lung cancer screening with computed tomography</article-title><source>Anticancer Res</source><volume>25</volume><year>2005</year><fpage>483</fpage><lpage>488</lpage><pub-id pub-id-type="pmid">15816616</pub-id></element-citation></ref><ref id="b0155"><label>31</label><element-citation publication-type="journal" id="h0155"><person-group person-group-type="author"><name name-style="western"><surname>McWilliams</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tammemagi</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Mayo</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Soghrati</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Probability of cancer in pulmonary nodules detected on first screening CT</article-title><source>N Engl J Med</source><volume>369</volume><year>2013</year><fpage>910</fpage><lpage>919</lpage><pub-id pub-id-type="pmid">24004118</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1214726</pub-id><pub-id pub-id-type="pmcid">PMC3951177</pub-id></element-citation></ref><ref id="b0160"><label>32</label><element-citation publication-type="journal" id="h0160"><person-group person-group-type="author"><name name-style="western"><surname>van Riel</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Ciompi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wille</surname><given-names>M.M.W.</given-names></name><name name-style="western"><surname>Dirksen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lam</surname><given-names>S.</given-names></name><name name-style="western"><surname>Scholten</surname><given-names>E.T.</given-names></name><etal/></person-group><article-title>Malignancy risk estimation of pulmonary nodules in screening CTs: comparison between a computer model and human observers</article-title><source>PLoS One</source><volume>12</volume><year>2017</year><fpage>e0185032</fpage><pub-id pub-id-type="pmid">29121063</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0185032</pub-id><pub-id pub-id-type="pmcid">PMC5679538</pub-id></element-citation></ref><ref id="b0165"><label>33</label><element-citation publication-type="journal" id="h0165"><person-group person-group-type="author"><name name-style="western"><surname>Wille</surname><given-names>M.M.W.</given-names></name><name name-style="western"><surname>van Riel</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Saghir</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Dirksen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Predictive accuracy of the pancan lung cancer risk prediction model &#8212; external validation based on CT from the Danish Lung Cancer Screening Trial</article-title><source>Eur Radiol</source><volume>25</volume><year>2015</year><fpage>3093</fpage><lpage>3099</lpage><pub-id pub-id-type="pmid">25764091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00330-015-3689-0</pub-id></element-citation></ref><ref id="b0170"><label>34</label><element-citation publication-type="journal" id="h0170"><person-group person-group-type="author"><name name-style="western"><surname>Kriegsmann</surname><given-names>M.</given-names></name><name name-style="western"><surname>Casadonte</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kriegsmann</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dienemann</surname><given-names>H.</given-names></name><name name-style="western"><surname>Schirmacher</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kobarg</surname><given-names>J.H.</given-names></name><etal/></person-group><article-title>Reliable entity subtyping in non-small cell lung cancer by matrix-assisted laser desorption/ionization imaging mass spectrometry on formalin-fixed paraffin-embedded tissue specimens</article-title><source>Mol Cell Proteomics</source><volume>15</volume><year>2016</year><fpage>3081</fpage><lpage>3089</lpage><pub-id pub-id-type="pmid">27473201</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/mcp.M115.057513</pub-id><pub-id pub-id-type="pmcid">PMC5054336</pub-id></element-citation></ref><ref id="b0175"><label>35</label><element-citation publication-type="journal" id="h0175"><person-group person-group-type="author"><name name-style="western"><surname>Mohammad</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Brennan</surname><given-names>P.C.</given-names></name><name name-style="western"><surname>Mello-Thoms</surname><given-names>C.</given-names></name></person-group><article-title>A review of lung cancer screening and the role of computer-aided detection</article-title><source>Clin Radiol</source><volume>72</volume><year>2017</year><fpage>433</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">28185635</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.crad.2017.01.002</pub-id></element-citation></ref><ref id="b0180"><label>36</label><element-citation publication-type="journal" id="h0180"><person-group person-group-type="author"><name name-style="western"><surname>Armato</surname><given-names>S.G.</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name><name name-style="western"><surname>Giger</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>MacMahon</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sone</surname><given-names>S.</given-names></name><name name-style="western"><surname>Doi</surname><given-names>K.</given-names></name></person-group><article-title>Lung cancer: performance of automated lung nodule detection applied to cancers missed in a CT screening program</article-title><source>Radiology</source><volume>225</volume><year>2002</year><fpage>685</fpage><lpage>692</lpage><pub-id pub-id-type="pmid">12461246</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiol.2253011376</pub-id></element-citation></ref><ref id="b0185"><label>37</label><element-citation publication-type="book" id="h0185"><person-group person-group-type="author"><name name-style="western"><surname>Buty</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bagci</surname><given-names>U.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mollura</surname><given-names>D.</given-names></name></person-group><part-title>Characterization of lung nodule malignancy using hybrid shape and appearance features</part-title><person-group person-group-type="editor"><name name-style="western"><surname>Ourselin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Joskowicz</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sabuncu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Unal</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wells</surname><given-names>W.</given-names></name></person-group><source>Medical image computing and computer-assisted intervention</source><year>2016</year><publisher-name>Springer</publisher-name><publisher-loc>Cham</publisher-loc><comment>p.662&#8211;70</comment></element-citation></ref><ref id="b0190"><label>38</label><element-citation publication-type="book" id="h0190"><person-group person-group-type="author"><name name-style="western"><surname>Hussein</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Bagci</surname><given-names>U.</given-names></name></person-group><part-title>Risk stratification of lung nodules using 3D CNN-based multi-task learning</part-title><person-group person-group-type="editor"><name name-style="western"><surname>Niethammer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Styner</surname><given-names>M.</given-names></name><name name-style="western"><surname>Aylward</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Oguz</surname><given-names>I.</given-names></name><name name-style="western"><surname>Yap</surname><given-names>P.T.</given-names></name></person-group><source>Information processing in medical imaging</source><year>2017</year><publisher-name>Springer</publisher-name><publisher-loc>Cham</publisher-loc><comment>p.249&#8211;60</comment></element-citation></ref><ref id="b0195"><label>39</label><element-citation publication-type="journal" id="h0195"><person-group person-group-type="author"><name name-style="western"><surname>Khosravan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Celik</surname><given-names>H.</given-names></name><name name-style="western"><surname>Turkbey</surname><given-names>B.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Wood</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bagci</surname><given-names>U.</given-names></name></person-group><article-title>A collaborative computer aided diagnosis (C-CAD) system with eye-tracking, sparse attentional model, and deep learning</article-title><source>Med Image Anal</source><volume>51</volume><year>2019</year><fpage>101</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">30399507</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.media.2018.10.010</pub-id><pub-id pub-id-type="pmcid">PMC6407631</pub-id></element-citation></ref><ref id="b0200"><label>40</label><element-citation publication-type="journal" id="h0200"><person-group person-group-type="author"><name name-style="western"><surname>Ciompi</surname><given-names>F.</given-names></name><name name-style="western"><surname>de Hoop</surname><given-names>B.</given-names></name><name name-style="western"><surname>van Riel</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>K.</given-names></name><name name-style="western"><surname>Scholten</surname><given-names>E.T.</given-names></name><name name-style="western"><surname>Oudkerk</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Automatic classification of pulmonary peri-fissural nodules in computed tomography using an ensemble of 2D views and a convolutional neural network out-of-the-box</article-title><source>Med Image Anal</source><volume>26</volume><year>2015</year><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">26458112</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.media.2015.08.001</pub-id></element-citation></ref><ref id="b0205"><label>41</label><element-citation publication-type="journal" id="h0205"><person-group person-group-type="author"><name name-style="western"><surname>Krizhevsky</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sutskever</surname><given-names>I.</given-names></name><name name-style="western"><surname>Hinton</surname><given-names>G.E.</given-names></name></person-group><article-title>Imagenet classification with deep convolutional neural networks</article-title><source>Commun ACM</source><volume>60</volume><year>2017</year><fpage>84</fpage><lpage>90</lpage></element-citation></ref><ref id="b0210"><label>42</label><element-citation publication-type="journal" id="h0210"><person-group person-group-type="author"><name name-style="western"><surname>Sermanet</surname><given-names>P.</given-names></name><name name-style="western"><surname>Eigen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Mathieu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fergus</surname><given-names>R.</given-names></name><name name-style="western"><surname>LeCun</surname><given-names>Y.</given-names></name></person-group><article-title>OverFeat: integrated recognition, localization and detection using convolutional networks</article-title><source>arXiv</source><year>2014</year><comment>1312.6229</comment></element-citation></ref><ref id="b0215"><label>43</label><element-citation publication-type="journal" id="h0215"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>T.F.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Yau</surname><given-names>S.T.</given-names></name></person-group><article-title>Genus zero surface conformal mapping and its application to brain surface mapping</article-title><source>Inf Process Med Imaging</source><volume>18</volume><year>2003</year><fpage>172</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">15344456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-3-540-45087-0_15</pub-id></element-citation></ref><ref id="b0220"><label>44</label><element-citation publication-type="journal" id="h0220"><person-group person-group-type="author"><name name-style="western"><surname>Venkadesh</surname><given-names>K.V.</given-names></name><name name-style="western"><surname>Setio</surname><given-names>A.A.A.</given-names></name><name name-style="western"><surname>Schreuder</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scholten</surname><given-names>E.T.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Wille</surname><given-names>M.M.W.</given-names></name><etal/></person-group><article-title>Deep learning for malignancy risk estimation of pulmonary nodules detected at low-dose screening CT</article-title><source>Radiology</source><volume>300</volume><year>2021</year><fpage>438</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">34003056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiol.2021204433</pub-id></element-citation></ref><ref id="b0225"><label>45</label><element-citation publication-type="journal" id="h0225"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J.</given-names></name></person-group><article-title>Deep residual learning for image recognition</article-title><source>IEEE Conf Comput Vis Pattern Recognit</source><year>2016</year><fpage>770</fpage><lpage>778</lpage></element-citation></ref><ref id="b0230"><label>46</label><element-citation publication-type="journal" id="h0230"><person-group person-group-type="author"><name name-style="western"><surname>Szegedy</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sermanet</surname><given-names>P.</given-names></name><name name-style="western"><surname>Reed</surname><given-names>S.</given-names></name><name name-style="western"><surname>Anguelov</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Going deeper with convolutions</article-title><source>IEEE Conf Comput Vis Pattern Recognit</source><year>2015</year><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="b0235"><label>47</label><element-citation publication-type="journal" id="h0235"><person-group person-group-type="author"><name name-style="western"><surname>Ardila</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kiraly</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Bharadwaj</surname><given-names>S.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Reicher</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>L.</given-names></name><etal/></person-group><article-title>End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography</article-title><source>Nat Med</source><volume>25</volume><year>2019</year><fpage>954</fpage><lpage>961</lpage><pub-id pub-id-type="pmid">31110349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-019-0447-x</pub-id></element-citation></ref><ref id="b0240"><label>48</label><element-citation publication-type="journal" id="h0240"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gkioxari</surname><given-names>G.</given-names></name><name name-style="western"><surname>Doll&#225;r</surname><given-names>P.</given-names></name><name name-style="western"><surname>Girshick</surname><given-names>R.</given-names></name></person-group><article-title>Mask R-CNN</article-title><source>IEEE Int Conf Comput Vis</source><year>2017</year><fpage>2980</fpage><lpage>2988</lpage></element-citation></ref><ref id="b0245"><label>49</label><element-citation publication-type="journal" id="h0245"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>T.Y.</given-names></name><name name-style="western"><surname>Goyal</surname><given-names>P.</given-names></name><name name-style="western"><surname>Girshick</surname><given-names>R.</given-names></name><name name-style="western"><surname>He</surname><given-names>K.</given-names></name><name name-style="western"><surname>Doll&#225;r</surname><given-names>P.</given-names></name></person-group><article-title>Focal loss for dense object detection</article-title><source>IEEE Trans Pattern Anal Mach Intell</source><volume>42</volume><year>2020</year><fpage>318</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">30040631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/TPAMI.2018.2858826</pub-id></element-citation></ref><ref id="b0250"><label>50</label><element-citation publication-type="journal" id="h0250"><person-group person-group-type="author"><name name-style="western"><surname>Carreira</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zisserman</surname><given-names>A.</given-names></name></person-group><article-title>Quo vadis, action recognition? A new model and the kinetics dataset</article-title><source>IEEE Conf Comput Vis Pattern Recognit</source><year>2017</year><fpage>4724</fpage><lpage>4733</lpage></element-citation></ref><ref id="b0255"><label>51</label><element-citation publication-type="journal" id="h0255"><person-group person-group-type="author"><name name-style="western"><surname>Szegedy</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vanhoucke</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ioffe</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shlens</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wojna</surname><given-names>Z.</given-names></name></person-group><article-title>Rethinking the inception architecture for computer vision</article-title><source>IEEE Conf Comput Vis Pattern Recognit</source><year>2016</year><fpage>2818</fpage><lpage>2826</lpage></element-citation></ref><ref id="b0260"><label>52</label><element-citation publication-type="journal" id="h0260"><person-group person-group-type="author"><name name-style="western"><surname>AbdulJabbar</surname><given-names>K.</given-names></name><name name-style="western"><surname>Raza</surname><given-names>S.E.A.</given-names></name><name name-style="western"><surname>Rosenthal</surname><given-names>R.</given-names></name><name name-style="western"><surname>Jamal-Hanjani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Veeriah</surname><given-names>S.</given-names></name><name name-style="western"><surname>Akarca</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Geospatial immune variability illuminates differential evolution of lung adenocarcinoma</article-title><source>Nat Med</source><volume>26</volume><year>2020</year><fpage>1054</fpage><lpage>1062</lpage><pub-id pub-id-type="pmid">32461698</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-020-0900-x</pub-id><pub-id pub-id-type="pmcid">PMC7610840</pub-id></element-citation></ref><ref id="b0265"><label>53</label><element-citation publication-type="journal" id="h0265"><person-group person-group-type="author"><name name-style="western"><surname>Raza</surname><given-names>S.E.A.</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>L.</given-names></name><name name-style="western"><surname>Shaban</surname><given-names>M.</given-names></name><name name-style="western"><surname>Graham</surname><given-names>S.</given-names></name><name name-style="western"><surname>Epstein</surname><given-names>D.</given-names></name><name name-style="western"><surname>Pelengaris</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Micro-Net: a unified model for segmentation of various objects in microscopy images</article-title><source>Med Image Anal</source><volume>52</volume><year>2019</year><fpage>160</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">30580111</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.media.2018.12.003</pub-id></element-citation></ref><ref id="b0270"><label>54</label><element-citation publication-type="journal" id="h0270"><person-group person-group-type="author"><name name-style="western"><surname>Sirinukunwattana</surname><given-names>K.</given-names></name><name name-style="western"><surname>Raza</surname><given-names>S.E.A.</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>Y.W.</given-names></name><name name-style="western"><surname>Snead</surname><given-names>D.R.J.</given-names></name><name name-style="western"><surname>Cree</surname><given-names>I.A.</given-names></name><name name-style="western"><surname>Rajpoot</surname><given-names>N.M.</given-names></name></person-group><article-title>Locality sensitive deep learning for detection and classification of nuclei in routine colon cancer histology images</article-title><source>IEEE Trans Med Imaging</source><volume>35</volume><year>2016</year><fpage>1196</fpage><lpage>1206</lpage><pub-id pub-id-type="pmid">26863654</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/TMI.2016.2525803</pub-id></element-citation></ref><ref id="b0275"><label>55</label><element-citation publication-type="journal" id="h0275"><person-group person-group-type="author"><name name-style="western"><surname>Ocampo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>A.</given-names></name><name name-style="western"><surname>Coudray</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sakellaropoulos</surname><given-names>T.</given-names></name><name name-style="western"><surname>Narula</surname><given-names>N.</given-names></name><name name-style="western"><surname>Snuderl</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning</article-title><source>J Thorac Oncol</source><volume>13</volume><year>2018</year><fpage>S562</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-018-0177-5</pub-id><pub-id pub-id-type="pmcid">PMC9847512</pub-id><pub-id pub-id-type="pmid">30224757</pub-id></element-citation></ref><ref id="b0280"><label>56</label><element-citation publication-type="journal" id="h0280"><person-group person-group-type="author"><name name-style="western"><surname>Yao</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S.K.</given-names></name></person-group><article-title>Label-free segmentation of COVID-19 lesions in lung CT</article-title><source>IEEE Trans Med Imaging</source><volume>40</volume><year>2021</year><fpage>2808</fpage><lpage>2819</lpage><pub-id pub-id-type="pmid">33760731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/TMI.2021.3066161</pub-id><pub-id pub-id-type="pmcid">PMC8544940</pub-id></element-citation></ref><ref id="b0285"><label>57</label><element-citation publication-type="journal" id="h0285"><person-group person-group-type="author"><name name-style="western"><surname>Chuquicusma</surname><given-names>MJM</given-names></name><name name-style="western"><surname>Hussein</surname><given-names>S</given-names></name><name name-style="western"><surname>Burt</surname><given-names>J</given-names></name><name name-style="western"><surname>Bagci</surname><given-names>U</given-names></name></person-group><article-title>How to fool radiologists with generative adversarial networks? A visual turing test for lung cancer diagnosis</article-title><source>IEEE Int Symp Biomed Imaging</source><year>2018</year><fpage>240</fpage><lpage>244</lpage></element-citation></ref><ref id="b0290"><label>58</label><mixed-citation publication-type="other" id="h0290">Li J, Jia J, Xu D. Unsupervised representation learning of image-based plant disease with deep convolutional generative adversarial networks. 37th Chinese Control Conference 2018:9159&#8211;63.</mixed-citation></ref><ref id="b0295"><label>59</label><element-citation publication-type="journal" id="h0295"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.H.</given-names></name></person-group><article-title>Using generative adversarial networks and parameter optimization of convolutional neural networks for lung tumor classification</article-title><source>Appl Sci</source><volume>11</volume><year>2021</year><fpage>480</fpage></element-citation></ref><ref id="b0300"><label>60</label><element-citation publication-type="journal" id="h0300"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name></person-group><article-title>A hybrid framework for lung cancer classification</article-title><source>Electronics</source><volume>11</volume><year>2022</year><fpage>1614</fpage><pub-id pub-id-type="pmid">36568860</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/electronics1010000</pub-id><pub-id pub-id-type="pmcid">PMC7613986</pub-id></element-citation></ref><ref id="b0305"><label>61</label><element-citation publication-type="journal" id="h0305"><person-group person-group-type="author"><name name-style="western"><surname>Pinsky</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Gierada</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Black</surname><given-names>W.</given-names></name><name name-style="western"><surname>Munden</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nath</surname><given-names>H.</given-names></name><name name-style="western"><surname>Aberle</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Performance of lung-RADS in the national lung screening trial: a retrospective assessment</article-title><source>Ann Intern Med</source><volume>162</volume><year>2015</year><fpage>485</fpage><lpage>491</lpage><pub-id pub-id-type="pmid">25664444</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/M14-2086</pub-id><pub-id pub-id-type="pmcid">PMC4705835</pub-id></element-citation></ref><ref id="b0310"><label>62</label><element-citation publication-type="journal" id="h0310"><person-group person-group-type="author"><name name-style="western"><surname>National Lung Screening Trial Research Team</surname></name><name name-style="western"><surname>Church</surname><given-names>T.R.</given-names></name><name name-style="western"><surname>Black</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Aberle</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Berg</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Clingan</surname><given-names>K.L.</given-names></name><etal/></person-group><article-title>Results of initial low-dose computed tomographic screening for lung cancer</article-title><source>N Engl J Med</source><volume>368</volume><year>2013</year><fpage>1980</fpage><lpage>1991</lpage><pub-id pub-id-type="pmid">23697514</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1209120</pub-id><pub-id pub-id-type="pmcid">PMC3762603</pub-id></element-citation></ref><ref id="b0315"><label>63</label><element-citation publication-type="journal" id="h0315"><person-group person-group-type="author"><name name-style="western"><surname>Herath</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rad</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Radfar</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ladwa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Warkiani</surname><given-names>M.</given-names></name><name name-style="western"><surname>O&#8217;Byrne</surname><given-names>K.</given-names></name><etal/></person-group><article-title>The role of circulating biomarkers in lung cancer</article-title><source>Front Oncol</source><volume>11</volume><year>2021</year><object-id pub-id-type="publisher-id">801269</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2021.801269</pub-id><pub-id pub-id-type="pmcid">PMC8813755</pub-id><pub-id pub-id-type="pmid">35127511</pub-id></element-citation></ref><ref id="b0320"><label>64</label><element-citation publication-type="journal" id="h0320"><person-group person-group-type="author"><name name-style="western"><surname>Politi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Herbst</surname><given-names>R.S.</given-names></name></person-group><article-title>Lung cancer in the era of precision medicine</article-title><source>Clin Cancer Res</source><volume>21</volume><year>2015</year><fpage>2213</fpage><lpage>2220</lpage><pub-id pub-id-type="pmid">25979927</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1078-0432.CCR-14-2748</pub-id><pub-id pub-id-type="pmcid">PMC4505624</pub-id></element-citation></ref><ref id="b0325"><label>65</label><element-citation publication-type="journal" id="h0325"><person-group person-group-type="author"><name name-style="western"><surname>Relli</surname><given-names>V.</given-names></name><name name-style="western"><surname>Trerotola</surname><given-names>M.</given-names></name><name name-style="western"><surname>Guerra</surname><given-names>E.</given-names></name><name name-style="western"><surname>Alberti</surname><given-names>S.</given-names></name></person-group><article-title>Abandoning the notion of non-small cell lung cancer</article-title><source>Trends Mol Med</source><volume>25</volume><year>2019</year><fpage>585</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">31155338</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molmed.2019.04.012</pub-id></element-citation></ref><ref id="b0330"><label>66</label><element-citation publication-type="journal" id="h0330"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Dhahbi</surname><given-names>J.</given-names></name></person-group><article-title>Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods</article-title><source>Sci Rep</source><volume>11</volume><year>2021</year><fpage>13323</fpage><pub-id pub-id-type="pmid">34172784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-021-92725-8</pub-id><pub-id pub-id-type="pmcid">PMC8233431</pub-id></element-citation></ref><ref id="b0335"><label>67</label><element-citation publication-type="journal" id="h0335"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Vo</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Clare</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name></person-group><article-title>Cancer classification and pathway discovery using non-negative matrix factorization</article-title><source>J Biomed Inform</source><volume>96</volume><year>2019</year><object-id pub-id-type="publisher-id">103247</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jbi.2019.103247</pub-id><pub-id pub-id-type="pmcid">PMC6697569</pub-id><pub-id pub-id-type="pmid">31271844</pub-id></element-citation></ref><ref id="b0340"><label>68</label><element-citation publication-type="journal" id="h0340"><person-group person-group-type="author"><name name-style="western"><surname>Jiao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Atwal</surname><given-names>G.</given-names></name><name name-style="western"><surname>Polak</surname><given-names>P.</given-names></name><name name-style="western"><surname>Karlic</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cuppen</surname><given-names>E.</given-names></name><name name-style="western"><surname>Danyi</surname><given-names>A.</given-names></name><etal/></person-group><article-title>A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns</article-title><source>Nat Commun</source><volume>11</volume><year>2020</year><fpage>728</fpage><pub-id pub-id-type="pmid">32024849</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-019-13825-8</pub-id><pub-id pub-id-type="pmcid">PMC7002586</pub-id></element-citation></ref><ref id="b0345"><label>69</label><element-citation publication-type="journal" id="h0345"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name></person-group><article-title>Performance-weighted-voting model: an ensemble machine learning method for cancer type classification using whole-exome sequencing mutation</article-title><source>Quant Biol</source><volume>8</volume><year>2020</year><fpage>347</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">34336363</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40484-020-0226-1</pub-id><pub-id pub-id-type="pmcid">PMC8320732</pub-id></element-citation></ref><ref id="b0350"><label>70</label><element-citation publication-type="journal" id="h0350"><person-group person-group-type="author"><name name-style="western"><surname>Eraslan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Avsec</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gagneur</surname><given-names>J.</given-names></name><name name-style="western"><surname>Theis</surname><given-names>F.J.</given-names></name></person-group><article-title>Deep learning: new computational modelling techniques for genomics</article-title><source>Nat Rev Genet</source><volume>20</volume><year>2019</year><fpage>389</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">30971806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41576-019-0122-6</pub-id></element-citation></ref><ref id="b0355"><label>71</label><mixed-citation publication-type="other" id="h0355">Luo Y, Mao C. Panther: pathway augmented nonnegative tensor factorization for higher-order feature learning. Proc AAAI Conf Artif Intell 2021:37&#8211;180.</mixed-citation></ref><ref id="b0360"><label>72</label><element-citation publication-type="journal" id="h0360"><person-group person-group-type="author"><name name-style="western"><surname>Shipp</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Ross</surname><given-names>K.N.</given-names></name><name name-style="western"><surname>Tamayo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Weng</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Kutok</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Aguiar</surname><given-names>R.C.T.</given-names></name><etal/></person-group><article-title>Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning</article-title><source>Nat Med</source><volume>8</volume><year>2002</year><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">11786909</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nm0102-68</pub-id></element-citation></ref><ref id="b0365"><label>73</label><element-citation publication-type="journal" id="h0365"><person-group person-group-type="author"><name name-style="western"><surname>Kononenko</surname><given-names>I.</given-names></name></person-group><article-title>Machine learning for medical diagnosis: history, state of the art and perspective</article-title><source>Artif Intell Med</source><volume>23</volume><year>2001</year><fpage>89</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">11470218</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0933-3657(01)00077-x</pub-id></element-citation></ref><ref id="b0370"><label>74</label><mixed-citation publication-type="other" id="h0370">Luo Y, Mao C. ScanMap: supervised confounding aware non-negative matrix factorization for polygenic risk modeling. Proc Mach Learn Res 2020;126:27&#8211;45.</mixed-citation></ref><ref id="b0375"><label>75</label><element-citation publication-type="journal" id="h0375"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Nugent</surname><given-names>J.O.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>S.A.</given-names></name><etal/></person-group><article-title>Deep learning for cancer type classification and driver gene identification</article-title><source>BMC Bioinformatics</source><volume>22</volume><year>2021</year><fpage>491</fpage><pub-id pub-id-type="pmid">34689757</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12859-021-04400-4</pub-id><pub-id pub-id-type="pmcid">PMC8543824</pub-id></element-citation></ref><ref id="b0380"><label>76</label><element-citation publication-type="journal" id="h0380"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Genetic load and potential mutational meltdown in cancer cell populations</article-title><source>Mol Biol Evol</source><volume>36</volume><year>2019</year><fpage>541</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">30649444</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/molbev/msy231</pub-id></element-citation></ref><ref id="b0385"><label>77</label><element-citation publication-type="journal" id="h0385"><person-group person-group-type="author"><name name-style="western"><surname>Alexandrov</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Nik-Zainal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wedge</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Aparicio</surname><given-names>S.A.J.R.</given-names></name><name name-style="western"><surname>Behjati</surname><given-names>S.</given-names></name><name name-style="western"><surname>Biankin</surname><given-names>A.V.</given-names></name><etal/></person-group><article-title>Signatures of mutational processes in human cancer</article-title><source>Nature</source><volume>500</volume><year>2013</year><fpage>415</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">23945592</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature12477</pub-id><pub-id pub-id-type="pmcid">PMC3776390</pub-id></element-citation></ref><ref id="b0390"><label>78</label><element-citation publication-type="journal" id="h0390"><person-group person-group-type="author"><name name-style="western"><surname>Mathios</surname><given-names>D.</given-names></name><name name-style="western"><surname>Johansen</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Cristiano</surname><given-names>S.</given-names></name><name name-style="western"><surname>Medina</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Phallen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Larsen</surname><given-names>K.R.</given-names></name><etal/></person-group><article-title>Detection and characterization of lung cancer using cell-free DNA fragmentomes</article-title><source>Nat Commun</source><volume>12</volume><year>2021</year><fpage>5060</fpage><pub-id pub-id-type="pmid">34417454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-021-24994-w</pub-id><pub-id pub-id-type="pmcid">PMC8379179</pub-id></element-citation></ref><ref id="b0395"><label>79</label><element-citation publication-type="journal" id="h0395"><person-group person-group-type="author"><name name-style="western"><surname>Chabon</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Hamilton</surname><given-names>E.G.</given-names></name><name name-style="western"><surname>Kurtz</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Esfahani</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Moding</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Stehr</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Integrating genomic features for non-invasive early lung cancer detection</article-title><source>Nature</source><volume>580</volume><year>2020</year><fpage>245</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">32269342</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-020-2140-0</pub-id><pub-id pub-id-type="pmcid">PMC8230734</pub-id></element-citation></ref><ref id="b0400"><label>80</label><element-citation publication-type="journal" id="h0400"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA)</article-title><source>Theranostics</source><volume>9</volume><year>2019</year><fpage>2056</fpage><lpage>2070</lpage><pub-id pub-id-type="pmid">31037156</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.28119</pub-id><pub-id pub-id-type="pmcid">PMC6485294</pub-id></element-citation></ref><ref id="b0405"><label>81</label><element-citation publication-type="journal" id="h0405"><person-group person-group-type="author"><name name-style="western"><surname>Raman</surname><given-names>L.</given-names></name><name name-style="western"><surname>van der Linden</surname><given-names>M.</given-names></name><name name-style="western"><surname>van der Eecken</surname><given-names>K.</given-names></name><name name-style="western"><surname>Vermaelen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Demedts</surname><given-names>I.</given-names></name><name name-style="western"><surname>Surmont</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma</article-title><source>Genome Med</source><volume>12</volume><year>2020</year><fpage>35</fpage><pub-id pub-id-type="pmid">32317009</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13073-020-00735-4</pub-id><pub-id pub-id-type="pmcid">PMC7175544</pub-id></element-citation></ref><ref id="b0410"><label>82</label><element-citation publication-type="book" id="h0410"><person-group person-group-type="author"><name name-style="western"><surname>Alberts</surname><given-names>B.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>J.</given-names></name><name name-style="western"><surname>Raff</surname><given-names>M.</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>K.</given-names></name><name name-style="western"><surname>Walter</surname><given-names>P.</given-names></name></person-group><part-title>Molecular biology of the cell</part-title><edition>4th ed.</edition><year>2002</year><publisher-name>Garland Science</publisher-name><publisher-loc>New York</publisher-loc></element-citation></ref><ref id="b0415"><label>83</label><element-citation publication-type="journal" id="h0415"><person-group person-group-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bolatkan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shiina</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hamamoto</surname><given-names>R.</given-names></name></person-group><article-title>Fully-connected neural networks with reduced parameterization for predicting histological types of lung cancer from somatic mutations</article-title><source>Biomolecules</source><volume>10</volume><year>2020</year><fpage>1249</fpage><pub-id pub-id-type="pmid">32872133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biom10091249</pub-id><pub-id pub-id-type="pmcid">PMC7563438</pub-id></element-citation></ref><ref id="b0420"><label>84</label><element-citation publication-type="journal" id="h0420"><person-group person-group-type="author"><name name-style="western"><surname>Lawrence</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Stojanov</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mermel</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Garraway</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Golub</surname><given-names>T.R.</given-names></name><etal/></person-group><article-title>Discovery and saturation analysis of cancer genes across 21 tumour types</article-title><source>Nature</source><volume>505</volume><year>2014</year><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">24390350</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature12912</pub-id><pub-id pub-id-type="pmcid">PMC4048962</pub-id></element-citation></ref><ref id="b0425"><label>85</label><element-citation publication-type="journal" id="h0425"><person-group person-group-type="author"><name name-style="western"><surname>Uhlen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sjostedt</surname><given-names>E.</given-names></name><name name-style="western"><surname>Fagerberg</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bidkhori</surname><given-names>G.</given-names></name><etal/></person-group><article-title>A pathology atlas of the human cancer transcriptome</article-title><source>Science</source><volume>357</volume><year>2017</year><fpage>eaan2507</fpage><pub-id pub-id-type="pmid">28818916</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aan2507</pub-id></element-citation></ref><ref id="b0430"><label>86</label><element-citation publication-type="journal" id="h0430"><person-group person-group-type="author"><name name-style="western"><surname>Whitney</surname><given-names>D.H.</given-names></name><name name-style="western"><surname>Elashoff</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Porta-Smith</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gower</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Vachani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>J.S.</given-names></name><etal/></person-group><article-title>Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy</article-title><source>BMC Med Genomics</source><volume>8</volume><year>2015</year><fpage>18</fpage><pub-id pub-id-type="pmid">25944280</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12920-015-0091-3</pub-id><pub-id pub-id-type="pmcid">PMC4434538</pub-id></element-citation></ref><ref id="b0435"><label>87</label><element-citation publication-type="journal" id="h0435"><person-group person-group-type="author"><name name-style="western"><surname>Podolsky</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Barchuk</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Kuznetcov</surname><given-names>V.I.</given-names></name><name name-style="western"><surname>Gusarova</surname><given-names>N.F.</given-names></name><name name-style="western"><surname>Gaidukov</surname><given-names>V.S.</given-names></name><name name-style="western"><surname>Tarakanov</surname><given-names>S.A.</given-names></name></person-group><article-title>Evaluation of machine learning algorithm utilization for lung cancer classification based on gene expression levels</article-title><source>Asian Pac J Cancer Prev</source><volume>17</volume><year>2016</year><fpage>835</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">26925688</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7314/apjcp.2016.17.2.835</pub-id></element-citation></ref><ref id="b0440"><label>88</label><element-citation publication-type="journal" id="h0440"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ning</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts</article-title><source>BMC Med Genomics</source><volume>13</volume><year>2020</year><fpage>151</fpage><pub-id pub-id-type="pmid">33087128</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12920-020-00782-1</pub-id><pub-id pub-id-type="pmcid">PMC7579926</pub-id></element-citation></ref><ref id="b0445"><label>89</label><mixed-citation publication-type="other" id="h0445">Aliferis CF, Tsamardinos I, Massion PP, Statnikov A, Fananapazir N, Hardin D. Machine learning models for classification of lung cancer and selection of genomic markers using array gene expression data. Proceedings of the 16th International Florida Artificial Intelligence Research Society Conference 2003:67&#8211;71.</mixed-citation></ref><ref id="b0450"><label>90</label><element-citation publication-type="journal" id="h0450"><person-group person-group-type="author"><name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>N.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Long</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ai</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Copy number variation is highly correlated with differential gene expression: a pan-cancer study</article-title><source>BMC Med Genet</source><volume>20</volume><year>2019</year><fpage>175</fpage><pub-id pub-id-type="pmid">31706287</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12881-019-0909-5</pub-id><pub-id pub-id-type="pmcid">PMC6842483</pub-id></element-citation></ref><ref id="b0455"><label>91</label><element-citation publication-type="journal" id="h0455"><person-group person-group-type="author"><name name-style="western"><surname>Aliferis</surname><given-names>C.F.</given-names></name><name name-style="western"><surname>Hardin</surname><given-names>D.</given-names></name><name name-style="western"><surname>Massion</surname><given-names>P.P.</given-names></name></person-group><article-title>Machine learning models for lung cancer classification using array comparative genomic hybridization</article-title><source>Proc AMIA Symp</source><year>2002</year><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">12463776</pub-id><pub-id pub-id-type="pmcid">PMC2244172</pub-id></element-citation></ref><ref id="b0460"><label>92</label><element-citation publication-type="journal" id="h0460"><person-group person-group-type="author"><name name-style="western"><surname>Daemen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gevaert</surname><given-names>O.</given-names></name><name name-style="western"><surname>Leunen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Legius</surname><given-names>E.</given-names></name><name name-style="western"><surname>Vergote</surname><given-names>I.</given-names></name><name name-style="western"><surname>De Moor</surname><given-names>B.</given-names></name></person-group><article-title>Supervised classification of array CGH data with HMM-based feature selection</article-title><source>Pac Symp Biocomput</source><year>2009</year><fpage>468</fpage><lpage>479</lpage><pub-id pub-id-type="pmid">19209723</pub-id></element-citation></ref><ref id="b0465"><label>93</label><element-citation publication-type="journal" id="h0465"><person-group person-group-type="author"><name name-style="western"><surname>Jurmeister</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bockmayr</surname><given-names>M.</given-names></name><name name-style="western"><surname>Seegerer</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bockmayr</surname><given-names>T.</given-names></name><name name-style="western"><surname>Treue</surname><given-names>D.</given-names></name><name name-style="western"><surname>Montavon</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases</article-title><source>Sci Transl Med</source><volume>11</volume><year>2019</year><fpage>eaaw8513</fpage><pub-id pub-id-type="pmid">31511427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.aaw8513</pub-id></element-citation></ref><ref id="b0470"><label>94</label><element-citation publication-type="journal" id="h0470"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Riedlinger</surname><given-names>G.</given-names></name><name name-style="western"><surname>Szolovits</surname><given-names>P.</given-names></name></person-group><article-title>Text mining in cancer gene and pathway prioritization</article-title><source>Cancer Inform</source><volume>13</volume><year>2014</year><fpage>69</fpage><lpage>79</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.4137/CIN.S13874</pub-id><pub-id pub-id-type="pmcid">PMC4216063</pub-id><pub-id pub-id-type="pmid">25392685</pub-id></element-citation></ref><ref id="b0475"><label>95</label><element-citation publication-type="journal" id="h0475"><person-group person-group-type="author"><name name-style="western"><surname>Guyon</surname><given-names>I.</given-names></name><name name-style="western"><surname>Weston</surname><given-names>J.</given-names></name><name name-style="western"><surname>Barnhill</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vapnik</surname><given-names>V.</given-names></name></person-group><article-title>Gene selection for cancer classification using support vector machines</article-title><source>Mach Learn</source><volume>46</volume><year>2002</year><fpage>389</fpage><lpage>422</lpage></element-citation></ref><ref id="b0480"><label>96</label><element-citation publication-type="journal" id="h0480"><person-group person-group-type="author"><name name-style="western"><surname>Mirhadi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tam</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Moghal</surname><given-names>N.</given-names></name><name name-style="western"><surname>Pham</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes</article-title><source>Nat Commun</source><volume>13</volume><year>2022</year><fpage>1811</fpage><pub-id pub-id-type="pmid">35383171</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-022-29444-9</pub-id><pub-id pub-id-type="pmcid">PMC8983714</pub-id></element-citation></ref><ref id="b0485"><label>97</label><element-citation publication-type="journal" id="h0485"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhai</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Integrative proteomic characterization of human lung adenocarcinoma</article-title><source>Cell</source><volume>182</volume><year>2020</year><fpage>245</fpage><lpage>261</lpage><pub-id pub-id-type="pmid">32649877</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2020.05.043</pub-id></element-citation></ref><ref id="b0490"><label>98</label><element-citation publication-type="journal" id="h0490"><person-group person-group-type="author"><name name-style="western"><surname>El-Deredy</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ashmore</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Branston</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Darling</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>D.G.</given-names></name></person-group><article-title>Pretreatment prediction of the chemotherapeutic response of human glioma cell cultures using nuclear magnetic resonance spectroscopy and artificial neural networks</article-title><source>Cancer Res</source><volume>57</volume><year>1997</year><fpage>4196</fpage><lpage>4199</lpage><pub-id pub-id-type="pmid">9331074</pub-id></element-citation></ref><ref id="b0495"><label>99</label><element-citation publication-type="journal" id="h0495"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Amin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Roy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pulliam</surname><given-names>N.E.</given-names></name><name name-style="western"><surname>Karavites</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Espino</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Preoperative magnetic resonance imaging use and oncologic outcomes in premenopausal breast cancer patients</article-title><source>NPJ Breast Cancer</source><volume>6</volume><year>2020</year><fpage>49</fpage><pub-id pub-id-type="pmid">33083528</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41523-020-00192-7</pub-id><pub-id pub-id-type="pmcid">PMC7532157</pub-id></element-citation></ref><ref id="b0500"><label>100</label><element-citation publication-type="journal" id="h0500"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Park</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K.Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>T.S.</given-names></name><etal/></person-group><article-title>Cancer drug response profile scan (CDRscan): a deep learning model that predicts drug effectiveness from cancer genomic signature</article-title><source>Sci Rep</source><volume>8</volume><year>2018</year><fpage>8857</fpage><pub-id pub-id-type="pmid">29891981</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-018-27214-6</pub-id><pub-id pub-id-type="pmcid">PMC5996063</pub-id></element-citation></ref><ref id="b0505"><label>101</label><element-citation publication-type="journal" id="h0505"><person-group person-group-type="author"><name name-style="western"><surname>Menden</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Iorio</surname><given-names>F.</given-names></name><name name-style="western"><surname>Garnett</surname><given-names>M.</given-names></name><name name-style="western"><surname>McDermott</surname><given-names>U.</given-names></name><name name-style="western"><surname>Benes</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Ballester</surname><given-names>P.J.</given-names></name><etal/></person-group><article-title>Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties</article-title><source>PLoS One</source><volume>8</volume><year>2013</year><fpage>e61318</fpage><pub-id pub-id-type="pmid">23646105</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0061318</pub-id><pub-id pub-id-type="pmcid">PMC3640019</pub-id></element-citation></ref><ref id="b0510"><label>102</label><element-citation publication-type="journal" id="h0510"><person-group person-group-type="author"><name name-style="western"><surname>Eisenhauer</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Therasse</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bogaerts</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Sargent</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ford</surname><given-names>R.</given-names></name><etal/></person-group><article-title>New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)</article-title><source>Eur J Cancer</source><volume>45</volume><year>2009</year><fpage>228</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">19097774</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejca.2008.10.026</pub-id></element-citation></ref><ref id="b0515"><label>103</label><element-citation publication-type="journal" id="h0515"><person-group person-group-type="author"><name name-style="western"><surname>Adam</surname><given-names>G.</given-names></name><name name-style="western"><surname>Rampasek</surname><given-names>L.</given-names></name><name name-style="western"><surname>Safikhani</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Smirnov</surname><given-names>P.</given-names></name><name name-style="western"><surname>Haibe-Kains</surname><given-names>B.</given-names></name><name name-style="western"><surname>Goldenberg</surname><given-names>A.</given-names></name></person-group><article-title>Machine learning approaches to drug response prediction: challenges and recent progress</article-title><source>NPJ Precis Oncol</source><volume>4</volume><year>2020</year><fpage>19</fpage><pub-id pub-id-type="pmid">32566759</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41698-020-0122-1</pub-id><pub-id pub-id-type="pmcid">PMC7296033</pub-id></element-citation></ref><ref id="b0520"><label>104</label><element-citation publication-type="journal" id="h0520"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Halpenny</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hellmann</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Deasy</surname><given-names>J.O.</given-names></name><etal/></person-group><article-title>Multiple resolution residually connected feature streams for automatic lung tumor segmentation from CT images</article-title><source>IEEE Trans Med Imaging</source><volume>38</volume><year>2019</year><fpage>134</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">30040632</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/TMI.2018.2857800</pub-id><pub-id pub-id-type="pmcid">PMC6402577</pub-id></element-citation></ref><ref id="b0525"><label>105</label><mixed-citation publication-type="other" id="h0525">Pohlen T, Hermans A, Mathias M, Leibe B. Full-resolution residual networks for semantic segmentation in street scenes. IEEE Conf Comput Vis Pattern Recognit 2017:3309&#8211;18.</mixed-citation></ref><ref id="b0530"><label>106</label><mixed-citation publication-type="other" id="h0530">Qureshi R. Personalized drug-response prediction model for lung cancer patients using machine learning. TechRxiv 2020; 13273319.v1.</mixed-citation></ref><ref id="b0535"><label>107</label><element-citation publication-type="journal" id="h0535"><person-group person-group-type="author"><name name-style="western"><surname>Kapil</surname><given-names>A.</given-names></name><name name-style="western"><surname>Meier</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zuraw</surname><given-names>A.</given-names></name><name name-style="western"><surname>Steele</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Rebelatto</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Deep semi supervised generative learning for automated tumor proportion scoring on NSCLC tissue needle biopsies</article-title><source>Sci Rep</source><volume>8</volume><year>2018</year><fpage>17343</fpage><pub-id pub-id-type="pmid">30478349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-018-35501-5</pub-id><pub-id pub-id-type="pmcid">PMC6255873</pub-id></element-citation></ref><ref id="b0540"><label>108</label><element-citation publication-type="journal" id="h0540"><person-group person-group-type="author"><name name-style="western"><surname>Otsu</surname><given-names>N.</given-names></name></person-group><article-title>A threshold selection method from gray-level histograms</article-title><source>IEEE Trans Syst Man Cybern</source><volume>9</volume><year>1979</year><fpage>62</fpage><lpage>66</lpage></element-citation></ref><ref id="b0545"><label>109</label><element-citation publication-type="journal" id="h0545"><person-group person-group-type="author"><name name-style="western"><surname>Geeleher</surname><given-names>P.</given-names></name><name name-style="western"><surname>Cox</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>R.S.</given-names></name></person-group><article-title>Clinical drug response can be predicted using baseline gene expression levels and <italic toggle="yes">in vitro</italic> drug sensitivity in cell lines</article-title><source>Genome Biol</source><volume>15</volume><year>2014</year><fpage>R47</fpage><pub-id pub-id-type="pmid">24580837</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/gb-2014-15-3-r47</pub-id><pub-id pub-id-type="pmcid">PMC4054092</pub-id></element-citation></ref><ref id="b0550"><label>110</label><element-citation publication-type="journal" id="h0550"><person-group person-group-type="author"><name name-style="western"><surname>Cule</surname><given-names>E.</given-names></name><name name-style="western"><surname>De Iorio</surname><given-names>M.</given-names></name></person-group><article-title>Ridge regression in prediction problems: automatic choice of the ridge parameter</article-title><source>Genet Epidemiol</source><volume>37</volume><year>2013</year><fpage>704</fpage><lpage>714</lpage><pub-id pub-id-type="pmid">23893343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/gepi.21750</pub-id><pub-id pub-id-type="pmcid">PMC4377081</pub-id></element-citation></ref><ref id="b0555"><label>111</label><mixed-citation publication-type="other" id="h0555">Quiros AC, Coudray N, Yeaton A, Yang X, Chiriboga L, Karimkhan A, et al. Self-supervised learning unveils morphological clusters behind lung cancer types and prognosis. arXiv 2022;2205.01931.</mixed-citation></ref><ref id="b0560"><label>112</label><element-citation publication-type="journal" id="h0560"><person-group person-group-type="author"><name name-style="western"><surname>Gensheimer</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Benson</surname><given-names>K.R.K.</given-names></name><name name-style="western"><surname>Carter</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Henry</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Wood</surname><given-names>D.J.</given-names></name><etal/></person-group><article-title>Automated model versus treating physician for predicting survival time of patients with metastatic cancer</article-title><source>J Am Med Inform Assoc</source><volume>28</volume><year>2021</year><fpage>1108</fpage><lpage>1116</lpage><pub-id pub-id-type="pmid">33313792</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jamia/ocaa290</pub-id><pub-id pub-id-type="pmcid">PMC8200275</pub-id></element-citation></ref><ref id="b0565"><label>113</label><element-citation publication-type="journal" id="h0565"><person-group person-group-type="author"><name name-style="western"><surname>Doppalapudi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Badr</surname><given-names>Y.</given-names></name></person-group><article-title>Lung cancer survival period prediction and understanding: deep learning approaches</article-title><source>Int J Med Inform</source><volume>148</volume><year>2021</year><object-id pub-id-type="publisher-id">104371</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijmedinf.2020.104371</pub-id><pub-id pub-id-type="pmid">33461009</pub-id></element-citation></ref><ref id="b0570"><label>114</label><element-citation publication-type="journal" id="h0570"><person-group person-group-type="author"><name name-style="western"><surname>Nair</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sandhu</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>A.K.</given-names></name></person-group><article-title>Prognostic and predictive biomarkers in cancer</article-title><source>Curr Cancer Drug Targets</source><volume>14</volume><year>2014</year><fpage>477</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">24807144</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1568009614666140506111118</pub-id></element-citation></ref><ref id="b0575"><label>115</label><element-citation publication-type="journal" id="h0575"><person-group person-group-type="author"><name name-style="western"><surname>Chow</surname><given-names>E.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>L.</given-names></name><name name-style="western"><surname>Panzarella</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hayter</surname><given-names>C.</given-names></name><name name-style="western"><surname>Szumacher</surname><given-names>E.</given-names></name><name name-style="western"><surname>Loblaw</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Accuracy of survival prediction by palliative radiation oncologists</article-title><source>Int J Radiat Oncol Biol Phys</source><volume>61</volume><year>2005</year><fpage>870</fpage><lpage>873</lpage><pub-id pub-id-type="pmid">15708268</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijrobp.2004.07.697</pub-id></element-citation></ref><ref id="b0580"><label>116</label><element-citation publication-type="journal" id="h0580"><person-group person-group-type="author"><name name-style="western"><surname>Lakin</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Bernacki</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Powers</surname><given-names>B.W.</given-names></name><name name-style="western"><surname>Block</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Estimating 1-year mortality for high-risk primary care patients using the &#8220;surprise&#8221; question</article-title><source>JAMA Intern Med</source><volume>176</volume><year>2016</year><fpage>1863</fpage><lpage>1865</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2016.5928</pub-id><pub-id pub-id-type="pmcid">PMC5755589</pub-id><pub-id pub-id-type="pmid">27695853</pub-id></element-citation></ref><ref id="b0585"><label>117</label><element-citation publication-type="journal" id="h0585"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>N.</given-names></name><name name-style="western"><surname>Reid</surname><given-names>F.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>A.</given-names></name><name name-style="western"><surname>Harries</surname><given-names>P.</given-names></name><name name-style="western"><surname>Stone</surname><given-names>P.</given-names></name></person-group><article-title>A systematic review of predictions of survival in palliative care: how accurate are clinicians and who are the experts?</article-title><source>PLoS One</source><volume>11</volume><year>2016</year><fpage>e0161407</fpage><pub-id pub-id-type="pmid">27560380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0161407</pub-id><pub-id pub-id-type="pmcid">PMC4999179</pub-id></element-citation></ref><ref id="b0590"><label>118</label><element-citation publication-type="journal" id="h0590"><person-group person-group-type="author"><name name-style="western"><surname>Cox</surname><given-names>D.R.</given-names></name></person-group><article-title>Regression models and life-tables</article-title><source>J R Stat Soc B</source><volume>34</volume><year>1972</year><fpage>187</fpage><lpage>220</lpage></element-citation></ref><ref id="b0595"><label>119</label><element-citation publication-type="journal" id="h0595"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Han</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Development and validation of a survival model for lung adenocarcinoma based on autophagy-associated genes</article-title><source>J Transl Med</source><volume>18</volume><year>2020</year><fpage>149</fpage><pub-id pub-id-type="pmid">32238163</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-020-02321-z</pub-id><pub-id pub-id-type="pmcid">PMC7115085</pub-id></element-citation></ref><ref id="b0600"><label>120</label><element-citation publication-type="journal" id="h0600"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y.M.</given-names></name></person-group><article-title>Development of a survival prognostic model for non-small cell lung cancer</article-title><source>Front Oncol</source><volume>10</volume><year>2020</year><fpage>362</fpage><pub-id pub-id-type="pmid">32266143</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2020.00362</pub-id><pub-id pub-id-type="pmcid">PMC7098984</pub-id></element-citation></ref><ref id="b0605"><label>121</label><element-citation publication-type="journal" id="h0605"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Berry</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Altman</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Re</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>D.L.</given-names></name><etal/></person-group><article-title>Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features</article-title><source>Nat Commun</source><volume>7</volume><year>2016</year><fpage>12474</fpage><pub-id pub-id-type="pmid">27527408</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncomms12474</pub-id><pub-id pub-id-type="pmcid">PMC4990706</pub-id></element-citation></ref><ref id="b0610"><label>122</label><element-citation publication-type="journal" id="h0610"><person-group person-group-type="author"><name name-style="western"><surname>Hatlen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Gronberg</surname><given-names>B.H.</given-names></name><name name-style="western"><surname>Langhammer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Carlsen</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Amundsen</surname><given-names>T.</given-names></name></person-group><article-title>Prolonged survival in patients with lung cancer with diabetes mellitus</article-title><source>J Thorac Oncol</source><volume>6</volume><year>2011</year><fpage>1810</fpage><lpage>1817</lpage><pub-id pub-id-type="pmid">21964531</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/JTO.0b013e31822a75be</pub-id></element-citation></ref><ref id="b0615"><label>123</label><element-citation publication-type="journal" id="h0615"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y.C.</given-names></name><name name-style="western"><surname>Ke</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>H.W.</given-names></name></person-group><article-title>Risk classification of cancer survival using ANN with gene expression data from multiple laboratories</article-title><source>Comput Biol Med</source><volume>48</volume><year>2014</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">24631783</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.compbiomed.2014.02.006</pub-id></element-citation></ref><ref id="b0620"><label>124</label><element-citation publication-type="journal" id="h0620"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Developing prognostic gene panel of survival time in lung adenocarcinoma patients using machine learning</article-title><source>Transl Cancer Res</source><volume>9</volume><year>2020</year><fpage>3860</fpage><lpage>3869</lpage><pub-id pub-id-type="pmid">35117753</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/tcr-19-2739</pub-id><pub-id pub-id-type="pmcid">PMC8799101</pub-id></element-citation></ref><ref id="b0625"><label>125</label><element-citation publication-type="journal" id="h0625"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><etal/></person-group><article-title>LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features</article-title><source>BMC Cancer</source><volume>19</volume><year>2019</year><fpage>263</fpage><pub-id pub-id-type="pmid">30902072</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12885-019-5433-7</pub-id><pub-id pub-id-type="pmcid">PMC6431052</pub-id></element-citation></ref><ref id="b0630"><label>126</label><element-citation publication-type="journal" id="h0630"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>Y.G.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D.H.</given-names></name></person-group><article-title>Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma</article-title><source>PLoS One</source><volume>13</volume><year>2018</year><fpage>e0207204</fpage><pub-id pub-id-type="pmid">30419062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0207204</pub-id><pub-id pub-id-type="pmcid">PMC6231670</pub-id></element-citation></ref><ref id="b0635"><label>127</label><element-citation publication-type="journal" id="h0635"><person-group person-group-type="author"><name name-style="western"><surname>Hui</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Shu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Han</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ge</surname><given-names>Q.</given-names></name><etal/></person-group><article-title>EBT: a statistic test identifying moderate size of significant features with balanced power and precision for genome-wide rate comparisons</article-title><source>Bioinformatics</source><volume>33</volume><year>2017</year><fpage>2631</fpage><lpage>2641</lpage><pub-id pub-id-type="pmid">28472273</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/btx294</pub-id></element-citation></ref><ref id="b0640"><label>128</label><element-citation publication-type="journal" id="h0640"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Berry</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Re</surname><given-names>C.</given-names></name><name name-style="western"><surname>Altman</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>M.</given-names></name></person-group><article-title>Association of omics features with histopathology patterns in lung adenocarcinoma</article-title><source>Cell Syst</source><volume>5</volume><year>2017</year><fpage>620</fpage><lpage>627</lpage><pub-id pub-id-type="pmid">29153840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cels.2017.10.014</pub-id><pub-id pub-id-type="pmcid">PMC5746468</pub-id></element-citation></ref><ref id="b0645"><label>129</label><element-citation publication-type="journal" id="h0645"><person-group person-group-type="author"><name name-style="western"><surname>Ramazzotti</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Batzoglou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sidow</surname><given-names>A.</given-names></name></person-group><article-title>Multi-omic tumor data reveal diversity of molecular mechanisms that correlate with survival</article-title><source>Nat Commun</source><volume>9</volume><year>2018</year><fpage>4453</fpage><pub-id pub-id-type="pmid">30367051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-018-06921-8</pub-id><pub-id pub-id-type="pmcid">PMC6203719</pub-id></element-citation></ref><ref id="b0650"><label>130</label><element-citation publication-type="journal" id="h0650"><person-group person-group-type="author"><name name-style="western"><surname>Asada</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Joutard</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tubaki</surname><given-names>M.</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Takasawa</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Uncovering prognosis-related genes and pathways by multi-omics analysis in lung cancer</article-title><source>Biomolecules</source><volume>10</volume><year>2020</year><fpage>524</fpage><pub-id pub-id-type="pmid">32235589</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biom10040524</pub-id><pub-id pub-id-type="pmcid">PMC7225957</pub-id></element-citation></ref><ref id="b0655"><label>131</label><element-citation publication-type="journal" id="h0655"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Asada</surname><given-names>K.</given-names></name><name name-style="western"><surname>Takasawa</surname><given-names>K.</given-names></name><name name-style="western"><surname>Shimoyama</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sakai</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bolatkan</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Predicting deep learning based multi-omics parallel integration survival subtypes in lung cancer using reverse phase protein array data</article-title><source>Biomolecules</source><volume>10</volume><year>2020</year><fpage>1460</fpage><pub-id pub-id-type="pmid">33086649</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biom10101460</pub-id><pub-id pub-id-type="pmcid">PMC7603376</pub-id></element-citation></ref><ref id="b0660"><label>132</label><element-citation publication-type="journal" id="h0660"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>PD-1/PD-L1 blockade therapy in advanced non-small-cell lung cancer: current status and future directions</article-title><source>Oncologist</source><volume>24</volume><year>2019</year><fpage>S31</fpage><lpage>S41</lpage><pub-id pub-id-type="pmid">30819829</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1634/theoncologist.2019-IO-S1-s05</pub-id><pub-id pub-id-type="pmcid">PMC6394772</pub-id></element-citation></ref><ref id="b0665"><label>133</label><element-citation publication-type="journal" id="h0665"><person-group person-group-type="author"><name name-style="western"><surname>Doroshow</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Sanmamed</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Hastings</surname><given-names>K.</given-names></name><name name-style="western"><surname>Politi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Rimm</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Immunotherapy in non-small cell lung cancer: facts and hopes</article-title><source>Clin Cancer Res</source><volume>25</volume><year>2019</year><fpage>4592</fpage><lpage>4602</lpage><pub-id pub-id-type="pmid">30824587</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1078-0432.CCR-18-1538</pub-id><pub-id pub-id-type="pmcid">PMC6679805</pub-id></element-citation></ref><ref id="b0670"><label>134</label><element-citation publication-type="journal" id="h0670"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.R.</given-names></name></person-group><article-title>Immunotherapy for non-small cell lung cancer: current landscape and future perspectives</article-title><source>Immune Netw</source><volume>20</volume><year>2020</year><fpage>e10</fpage><pub-id pub-id-type="pmid">32158598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4110/in.2020.20.e10</pub-id><pub-id pub-id-type="pmcid">PMC7049584</pub-id></element-citation></ref><ref id="b0675"><label>135</label><element-citation publication-type="journal" id="h0675"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z.</given-names></name></person-group><article-title>Applying artificial intelligence for cancer immunotherapy</article-title><source>Acta Pharm Sin B</source><volume>11</volume><year>2021</year><fpage>3393</fpage><lpage>3405</lpage><pub-id pub-id-type="pmid">34900525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.apsb.2021.02.007</pub-id><pub-id pub-id-type="pmcid">PMC8642413</pub-id></element-citation></ref><ref id="b0680"><label>136</label><element-citation publication-type="journal" id="h0680"><person-group person-group-type="author"><name name-style="western"><surname>Wiesweg</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mairinger</surname><given-names>F.</given-names></name><name name-style="western"><surname>Reis</surname><given-names>H.</given-names></name><name name-style="western"><surname>Goetz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kollmeier</surname><given-names>J.</given-names></name><name name-style="western"><surname>Misch</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Machine learning reveals a PD-L1-independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context</article-title><source>Eur J Cancer</source><volume>140</volume><year>2020</year><fpage>76</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">33059196</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejca.2020.09.015</pub-id></element-citation></ref><ref id="b0685"><label>137</label><element-citation publication-type="journal" id="h0685"><person-group person-group-type="author"><name name-style="western"><surname>Trebeschi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Drago</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Birkbak</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Kurilova</surname><given-names>I.</given-names></name><name name-style="western"><surname>Calin</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Pizzi</surname><given-names>A.D.</given-names></name><etal/></person-group><article-title>Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers</article-title><source>Ann Oncol</source><volume>30</volume><year>2019</year><fpage>998</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">30895304</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/annonc/mdz108</pub-id><pub-id pub-id-type="pmcid">PMC6594459</pub-id></element-citation></ref><ref id="b0690"><label>138</label><element-citation publication-type="journal" id="h0690"><person-group person-group-type="author"><name name-style="western"><surname>Coroller</surname><given-names>T.P.</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>V.</given-names></name><name name-style="western"><surname>Narayan</surname><given-names>V.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Grossmann</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.W.</given-names></name><etal/></person-group><article-title>Radiomic phenotype features predict pathological response in non-small cell lung cancer</article-title><source>Radiother Oncol</source><volume>119</volume><year>2016</year><fpage>480</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">27085484</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.radonc.2016.04.004</pub-id><pub-id pub-id-type="pmcid">PMC4930885</pub-id></element-citation></ref><ref id="b0695"><label>139</label><element-citation publication-type="journal" id="h0695"><person-group person-group-type="author"><name name-style="western"><surname>Tosolini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pont</surname><given-names>F.</given-names></name><name name-style="western"><surname>Poupot</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vergez</surname><given-names>F.</given-names></name><name name-style="western"><surname>Nicolau-Travers</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Vermijlen</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Assessment of tumor-infiltrating TCRV&#947;9V&#948;2 &#947;&#948; lymphocyte abundance by deconvolution of human cancers microarrays</article-title><source>Oncoimmunology</source><volume>6</volume><year>2017</year><fpage>e1284723</fpage><pub-id pub-id-type="pmid">28405516</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/2162402X.2017.1284723</pub-id><pub-id pub-id-type="pmcid">PMC5384348</pub-id></element-citation></ref><ref id="b0700"><label>140</label><element-citation publication-type="journal" id="h0700"><person-group person-group-type="author"><name name-style="western"><surname>Newman</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Green</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Gentles</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Robust enumeration of cell subsets from tissue expression profiles</article-title><source>Nat Methods</source><volume>12</volume><year>2015</year><fpage>453</fpage><lpage>457</lpage><pub-id pub-id-type="pmid">25822800</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nmeth.3337</pub-id><pub-id pub-id-type="pmcid">PMC4739640</pub-id></element-citation></ref><ref id="b0705"><label>141</label><element-citation publication-type="journal" id="h0705"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>R.</given-names></name><name name-style="western"><surname>Limkin</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Vakalopoulou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dercle</surname><given-names>L.</given-names></name><name name-style="western"><surname>Champiat</surname><given-names>S.</given-names></name><name name-style="western"><surname>Han</surname><given-names>S.R.</given-names></name><etal/></person-group><article-title>A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study</article-title><source>Lancet Oncol</source><volume>19</volume><year>2018</year><fpage>1180</fpage><lpage>1191</lpage><pub-id pub-id-type="pmid">30120041</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1470-2045(18)30413-3</pub-id></element-citation></ref><ref id="b0710"><label>142</label><element-citation publication-type="journal" id="h0710"><person-group person-group-type="author"><name name-style="western"><surname>Saltz</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kurc</surname><given-names>T.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>P.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images</article-title><source>Cell Rep</source><volume>23</volume><year>2018</year><fpage>181</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">29617659</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2018.03.086</pub-id><pub-id pub-id-type="pmcid">PMC5943714</pub-id></element-citation></ref><ref id="b0715"><label>143</label><element-citation publication-type="journal" id="h0715"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>L.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kanevsky</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Samaras</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kurc</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Sparse autoencoder for unsupervised nucleus detection and representation in histopathology images</article-title><source>Pattern Recognit</source><volume>86</volume><year>2019</year><fpage>188</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">30631215</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.patcog.2018.09.007</pub-id><pub-id pub-id-type="pmcid">PMC6322841</pub-id></element-citation></ref><ref id="b0720"><label>144</label><element-citation publication-type="journal" id="h0720"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>Z.P.</given-names></name><name name-style="western"><surname>Ai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>E.I.C.</given-names></name></person-group><article-title>Deep convolutional activation features for large scale brain tumor histopathology image classification and segmentation</article-title><source>IEEE Int Conf Acoust Spee Signal Process</source><year>2015</year><fpage>947</fpage><lpage>951</lpage></element-citation></ref><ref id="b0725"><label>145</label><element-citation publication-type="journal" id="h0725"><person-group person-group-type="author"><name name-style="western"><surname>Noh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>S.</given-names></name><name name-style="western"><surname>Han</surname><given-names>B.</given-names></name></person-group><article-title>Learning deconvolution network for semantic segmentation</article-title><source>IEEE Int Conf Comp Vis</source><year>2015</year><fpage>1520</fpage><lpage>1528</lpage></element-citation></ref><ref id="b0730"><label>146</label><element-citation publication-type="journal" id="h0730"><person-group person-group-type="author"><name name-style="western"><surname>De Mattos-Arruda</surname><given-names>L.</given-names></name><name name-style="western"><surname>Vazquez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Finotello</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lepore</surname><given-names>R.</given-names></name><name name-style="western"><surname>Porta</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hundal</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Neoantigen prediction and computational perspectives towards clinical benefit: Recommendations from the ESMO precision medicine working group</article-title><source>Ann Oncol</source><volume>31</volume><year>2020</year><fpage>978</fpage><lpage>990</lpage><pub-id pub-id-type="pmid">32610166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.annonc.2020.05.008</pub-id><pub-id pub-id-type="pmcid">PMC7885309</pub-id></element-citation></ref><ref id="b0735"><label>147</label><element-citation publication-type="journal" id="h0735"><person-group person-group-type="author"><name name-style="western"><surname>Roudko</surname><given-names>V.</given-names></name><name name-style="western"><surname>Greenbaum</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bhardwaj</surname><given-names>N.</given-names></name></person-group><article-title>Computational prediction and validation of tumor-associated neoantigens</article-title><source>Front Immunol</source><volume>11</volume><year>2020</year><fpage>27</fpage><pub-id pub-id-type="pmid">32117226</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2020.00027</pub-id><pub-id pub-id-type="pmcid">PMC7025577</pub-id></element-citation></ref><ref id="b0740"><label>148</label><element-citation publication-type="journal" id="h0740"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Su</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Neoantigen: a new breakthrough in tumor immunotherapy</article-title><source>Front Immunol</source><volume>12</volume><year>2021</year><object-id pub-id-type="publisher-id">672356</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2021.672356</pub-id><pub-id pub-id-type="pmcid">PMC8085349</pub-id><pub-id pub-id-type="pmid">33936118</pub-id></element-citation></ref><ref id="b0745"><label>149</label><element-citation publication-type="journal" id="h0745"><person-group person-group-type="author"><name name-style="western"><surname>Hilf</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kuttruff-Coqui</surname><given-names>S.</given-names></name><name name-style="western"><surname>Frenzel</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bukur</surname><given-names>V.</given-names></name><name name-style="western"><surname>Stevanovic</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gouttefangeas</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Actively personalized vaccination trial for newly diagnosed glioblastoma</article-title><source>Nature</source><volume>565</volume><year>2019</year><fpage>240</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">30568303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-018-0810-y</pub-id></element-citation></ref><ref id="b0750"><label>150</label><element-citation publication-type="journal" id="h0750"><person-group person-group-type="author"><name name-style="western"><surname>Carreno</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Magrini</surname><given-names>V.</given-names></name><name name-style="western"><surname>Becker-Hapak</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kaabinejadian</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hundal</surname><given-names>J.</given-names></name><name name-style="western"><surname>Petti</surname><given-names>A.A.</given-names></name><etal/></person-group><article-title>A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells</article-title><source>Science</source><volume>348</volume><year>2015</year><fpage>803</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">25837513</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aaa3828</pub-id><pub-id pub-id-type="pmcid">PMC4549796</pub-id></element-citation></ref><ref id="b0755"><label>151</label><element-citation publication-type="journal" id="h0755"><person-group person-group-type="author"><name name-style="western"><surname>Ott</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Keskin</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Shukla</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bozym</surname><given-names>D.J.</given-names></name><etal/></person-group><article-title>An immunogenic personal neoantigen vaccine for patients with melanoma</article-title><source>Nature</source><volume>547</volume><year>2017</year><fpage>217</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">28678778</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature22991</pub-id><pub-id pub-id-type="pmcid">PMC5577644</pub-id></element-citation></ref><ref id="b0760"><label>152</label><element-citation publication-type="journal" id="h0760"><person-group person-group-type="author"><name name-style="western"><surname>Keskin</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Anandappa</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tirosh</surname><given-names>I.</given-names></name><name name-style="western"><surname>Mathewson</surname><given-names>N.D.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial</article-title><source>Nature</source><volume>565</volume><year>2019</year><fpage>234</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">30568305</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-018-0792-9</pub-id><pub-id pub-id-type="pmcid">PMC6546179</pub-id></element-citation></ref><ref id="b0765"><label>153</label><element-citation publication-type="journal" id="h0765"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Sher</surname><given-names>X.</given-names></name></person-group><article-title>Systematically benchmarking peptide-MHC binding predictors: from synthetic to naturally processed epitopes</article-title><source>PLoS Comput Biol</source><volume>14</volume><year>2018</year><fpage>e1006457</fpage><pub-id pub-id-type="pmid">30408041</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pcbi.1006457</pub-id><pub-id pub-id-type="pmcid">PMC6224037</pub-id></element-citation></ref><ref id="b0770"><label>154</label><element-citation publication-type="journal" id="h0770"><person-group person-group-type="author"><name name-style="western"><surname>Racle</surname><given-names>J.</given-names></name><name name-style="western"><surname>Michaux</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rockinger</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Arnaud</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bobisse</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chong</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes</article-title><source>Nat Biotechnol</source><volume>37</volume><year>2019</year><fpage>1283</fpage><lpage>1286</lpage><pub-id pub-id-type="pmid">31611696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41587-019-0289-6</pub-id></element-citation></ref><ref id="b0775"><label>155</label><element-citation publication-type="journal" id="h0775"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>B.B.</given-names></name><name name-style="western"><surname>Khodadoust</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Olsson</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wagar</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>Fast</surname><given-names>E.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.L.</given-names></name><etal/></person-group><article-title>Predicting HLA class II antigen presentation through integrated deep learning</article-title><source>Nature Biotechnol</source><volume>37</volume><year>2019</year><fpage>1332</fpage><lpage>1343</lpage><pub-id pub-id-type="pmid">31611695</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41587-019-0280-2</pub-id><pub-id pub-id-type="pmcid">PMC7075463</pub-id></element-citation></ref><ref id="b0780"><label>156</label><element-citation publication-type="journal" id="h0780"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Donnell</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Rubinsteyn</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bonsack</surname><given-names>M.</given-names></name><name name-style="western"><surname>Riemer</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Laserson</surname><given-names>U.</given-names></name><name name-style="western"><surname>Hammerbacher</surname><given-names>J.</given-names></name></person-group><article-title>MHCflurry: open-source class I MHC binding affinity prediction</article-title><source>Cell Syst</source><volume>7</volume><year>2018</year><fpage>129</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">29960884</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cels.2018.05.014</pub-id></element-citation></ref><ref id="b0785"><label>157</label><element-citation publication-type="journal" id="h0785"><person-group person-group-type="author"><name name-style="western"><surname>Bulik-Sullivan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Busby</surname><given-names>J.</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>T.</given-names></name><name name-style="western"><surname>Clark</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification</article-title><source>Nature Biotechnol</source><volume>37</volume><year>2019</year><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nbt.4313</pub-id><pub-id pub-id-type="pmid">30556813</pub-id></element-citation></ref><ref id="b0790"><label>158</label><element-citation publication-type="journal" id="h0790"><person-group person-group-type="author"><name name-style="western"><surname>Lundegaard</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lamberth</surname><given-names>K.</given-names></name><name name-style="western"><surname>Harndahl</surname><given-names>M.</given-names></name><name name-style="western"><surname>Buus</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lund</surname><given-names>O.</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>M.</given-names></name></person-group><article-title>NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8&#8211;11</article-title><source>Nucleic Acids Res</source><volume>36</volume><year>2008</year><fpage>W509</fpage><lpage>W512</lpage><pub-id pub-id-type="pmid">18463140</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkn202</pub-id><pub-id pub-id-type="pmcid">PMC2447772</pub-id></element-citation></ref><ref id="b0795"><label>159</label><element-citation publication-type="journal" id="h0795"><person-group person-group-type="author"><name name-style="western"><surname>Nielsen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lundegaard</surname><given-names>C.</given-names></name><name name-style="western"><surname>Worning</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lauemoller</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Lamberth</surname><given-names>K.</given-names></name><name name-style="western"><surname>Buus</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Reliable prediction of T-cell epitopes using neural networks with novel sequence representations</article-title><source>Protein Sci</source><volume>12</volume><year>2003</year><fpage>1007</fpage><lpage>1017</lpage><pub-id pub-id-type="pmid">12717023</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1110/ps.0239403</pub-id><pub-id pub-id-type="pmcid">PMC2323871</pub-id></element-citation></ref><ref id="b0800"><label>160</label><element-citation publication-type="journal" id="h0800"><person-group person-group-type="author"><name name-style="western"><surname>Buus</surname><given-names>S.</given-names></name><name name-style="western"><surname>Stryhn</surname><given-names>A.</given-names></name><name name-style="western"><surname>Winther</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kirkby</surname><given-names>N.</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>L.O.</given-names></name></person-group><article-title>Receptor-ligand interactions measured by an improved spun column chromatography technique. a high efficiency and high throughput size separation method</article-title><source>Biochim Biophys Acta</source><volume>1243</volume><year>1995</year><fpage>453</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">7537104</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0304-4165(94)00172-t</pub-id></element-citation></ref><ref id="b0805"><label>161</label><element-citation publication-type="journal" id="h0805"><person-group person-group-type="author"><name name-style="western"><surname>Jurtz</surname><given-names>V.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>S.</given-names></name><name name-style="western"><surname>Andreatta</surname><given-names>M.</given-names></name><name name-style="western"><surname>Marcatili</surname><given-names>P.</given-names></name><name name-style="western"><surname>Peters</surname><given-names>B.</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>M.</given-names></name></person-group><article-title>NetMHCpan-4.0: Improved peptide&#8211;MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data</article-title><source>J Immunol</source><volume>199</volume><year>2017</year><fpage>3360</fpage><lpage>3368</lpage><pub-id pub-id-type="pmid">28978689</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1700893</pub-id><pub-id pub-id-type="pmcid">PMC5679736</pub-id></element-citation></ref><ref id="b0810"><label>162</label><element-citation publication-type="journal" id="h0810"><person-group person-group-type="author"><name name-style="western"><surname>Nielsen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lundegaard</surname><given-names>C.</given-names></name><name name-style="western"><surname>Blicher</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lamberth</surname><given-names>K.</given-names></name><name name-style="western"><surname>Harndahl</surname><given-names>M.</given-names></name><name name-style="western"><surname>Justesen</surname><given-names>S.</given-names></name><etal/></person-group><article-title>NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence</article-title><source>PLoS One</source><volume>2</volume><year>2007</year><fpage>e796</fpage><pub-id pub-id-type="pmid">17726526</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0000796</pub-id><pub-id pub-id-type="pmcid">PMC1949492</pub-id></element-citation></ref><ref id="b0815"><label>163</label><element-citation publication-type="journal" id="h0815"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>L.</given-names></name><name name-style="western"><surname>Creaney</surname><given-names>J.</given-names></name><name name-style="western"><surname>Redwood</surname><given-names>A.</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>B.</given-names></name></person-group><article-title>The current lung cancer neoantigen landscape and implications for therapy</article-title><source>J Thorac Oncol</source><volume>16</volume><year>2021</year><fpage>922</fpage><lpage>932</lpage><pub-id pub-id-type="pmid">33581342</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jtho.2021.01.1624</pub-id></element-citation></ref><ref id="b0820"><label>164</label><element-citation publication-type="journal" id="h0820"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>L.</given-names></name><name name-style="western"><surname>He</surname><given-names>R.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>T.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Neoantigen load as a prognostic and predictive marker for stage II/III non-small cell lung cancer in chinese patients</article-title><source>Thorac Cancer</source><volume>12</volume><year>2021</year><fpage>2170</fpage><lpage>2181</lpage><pub-id pub-id-type="pmid">34128337</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1759-7714.14046</pub-id><pub-id pub-id-type="pmcid">PMC8327700</pub-id></element-citation></ref><ref id="b0825"><label>165</label><element-citation publication-type="journal" id="h0825"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Personal neoantigens from patients with NSCLC induce efficient antitumor responses</article-title><source>Front Oncol</source><volume>11</volume><year>2021</year><fpage>628456</fpage><pub-id pub-id-type="pmid">33928024</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2021.628456</pub-id><pub-id pub-id-type="pmcid">PMC8076796</pub-id></element-citation></ref><ref id="b0830"><label>166</label><element-citation publication-type="journal" id="h0830"><person-group person-group-type="author"><name name-style="western"><surname>Zou</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Y.</given-names></name></person-group><article-title>A technical review of convolutional neural network-based mammographic breast cancer diagnosis</article-title><source>Comput Math Methods Med</source><volume>2019</volume><year>2019</year><fpage>6509357</fpage><pub-id pub-id-type="pmid">31019547</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2019/6509357</pub-id><pub-id pub-id-type="pmcid">PMC6452645</pub-id></element-citation></ref><ref id="b0835"><label>167</label><element-citation publication-type="journal" id="h0835"><person-group person-group-type="author"><name name-style="western"><surname>LeCun</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bengio</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hinton</surname><given-names>G.</given-names></name></person-group><article-title>Deep learning</article-title><source>Nature</source><volume>521</volume><year>2015</year><fpage>436</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">26017442</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature14539</pub-id></element-citation></ref><ref id="b0840"><label>168</label><element-citation publication-type="journal" id="h0840"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name></person-group><article-title>ImageGCN: multi-relational image graph convolutional networks for disease identification with chest X-rays</article-title><source>IEEE Trans Med Imaging</source><volume>41</volume><year>2022</year><fpage>1990</fpage><lpage>2003</lpage><pub-id pub-id-type="pmid">35192461</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/TMI.2022.3153322</pub-id><pub-id pub-id-type="pmcid">PMC9367633</pub-id></element-citation></ref><ref id="b0845"><label>169</label><element-citation publication-type="journal" id="h0845"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name></person-group><article-title>Deep generative classifiers for thoracic disease diagnosis with chest X-ray images</article-title><source>Proceedings (IEEE Int Conf Bioinformatics Biomed)</source><volume>2018</volume><year>2018</year><fpage>1209</fpage><lpage>1214</lpage><pub-id pub-id-type="pmid">31341701</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/BIBM.2018.8621107</pub-id><pub-id pub-id-type="pmcid">PMC6651749</pub-id></element-citation></ref><ref id="b0850"><label>170</label><mixed-citation publication-type="other" id="h0850">Dosovitskiy A, Beyer L, Kolesnikov A, Weissenborn D, Zhai X, Unterthiner T, et al. An image is worth 16 &#215; 16 words: transformers for image recognition at scale. arXiv 2020;2010.11929.</mixed-citation></ref><ref id="b0855"><label>171</label><mixed-citation publication-type="other" id="h0855">Khan S, Naseer M, Hayat M, Zamir SW, Khan F, Shah M. Transformers in vision: a survey. arXiv 2022;2101.01169.</mixed-citation></ref><ref id="b0860"><label>172</label><mixed-citation publication-type="other" id="h0860">Boesch G. Vision transformers (ViT) in image recognition - 2022 guide [Internet]. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://viso.ai/deep-learning/vision-transformer-vit/" id="ir010">https://viso.ai/deep-learning/vision-transformer-vit/</ext-link>.</mixed-citation></ref><ref id="b0865"><label>173</label><element-citation publication-type="journal" id="h0865"><person-group person-group-type="author"><name name-style="western"><surname>Hie</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>E.D.</given-names></name><name name-style="western"><surname>Berger</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bryson</surname><given-names>B.</given-names></name></person-group><article-title>Learning the language of viral evolution and escape</article-title><source>Science</source><volume>371</volume><year>2021</year><fpage>284</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">33446556</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.abd7331</pub-id></element-citation></ref><ref id="b0870"><label>174</label><element-citation publication-type="journal" id="h0870"><person-group person-group-type="author"><name name-style="western"><surname>Flagel</surname><given-names>L.</given-names></name><name name-style="western"><surname>Brandvain</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Schrider</surname><given-names>D.R.</given-names></name></person-group><article-title>The unreasonable effectiveness of convolutional neural networks in population genetic inference</article-title><source>Mol Biol Evol</source><volume>36</volume><year>2019</year><fpage>220</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">30517664</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/molbev/msy224</pub-id><pub-id pub-id-type="pmcid">PMC6367976</pub-id></element-citation></ref><ref id="b0875"><label>175</label><element-citation publication-type="journal" id="h0875"><person-group person-group-type="author"><name name-style="western"><surname>Lopez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Regier</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cole</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Jordan</surname><given-names>M.I.</given-names></name><name name-style="western"><surname>Yosef</surname><given-names>N.</given-names></name></person-group><article-title>Deep generative modeling for single-cell transcriptomics</article-title><source>Nat Methods</source><volume>15</volume><year>2018</year><fpage>1053</fpage><lpage>1058</lpage><pub-id pub-id-type="pmid">30504886</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41592-018-0229-2</pub-id><pub-id pub-id-type="pmcid">PMC6289068</pub-id></element-citation></ref><ref id="b0880"><label>176</label><element-citation publication-type="journal" id="h0880"><person-group person-group-type="author"><name name-style="western"><surname>Hashim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nandakumar</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yaqub</surname><given-names>M.</given-names></name></person-group><article-title>SubOmiEmbed: self-supervised representation learning of multi-omics data for cancer type classification</article-title><source>10th Int Conf Bioinform Comput Biol</source><year>2022</year><fpage>66</fpage><lpage>72</lpage></element-citation></ref><ref id="b0885"><label>177</label><element-citation publication-type="journal" id="h0885"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hyeon</surname><given-names>D.Y.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>D.</given-names></name></person-group><article-title>Single-cell multiomics: technologies and data analysis methods</article-title><source>Exp Mol Med</source><volume>52</volume><year>2020</year><fpage>1428</fpage><lpage>1442</lpage><pub-id pub-id-type="pmid">32929225</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s12276-020-0420-2</pub-id><pub-id pub-id-type="pmcid">PMC8080692</pub-id></element-citation></ref><ref id="b0890"><label>178</label><element-citation publication-type="journal" id="h0890"><person-group person-group-type="author"><name name-style="western"><surname>Rao</surname><given-names>A.</given-names></name><name name-style="western"><surname>Barkley</surname><given-names>D.</given-names></name><name name-style="western"><surname>Franca</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Yanai</surname><given-names>I.</given-names></name></person-group><article-title>Exploring tissue architecture using spatial transcriptomics</article-title><source>Nature</source><volume>596</volume><year>2021</year><fpage>211</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">34381231</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-021-03634-9</pub-id><pub-id pub-id-type="pmcid">PMC8475179</pub-id></element-citation></ref><ref id="b0895"><label>179</label><element-citation publication-type="journal" id="h0895"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name></person-group><article-title>Using an unsupervised clustering model to detect the early spread of SARS-CoV-2 worldwide</article-title><source>Genes</source><volume>13</volume><year>2022</year><fpage>648</fpage><pub-id pub-id-type="pmid">35456454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/genes13040648</pub-id><pub-id pub-id-type="pmcid">PMC9030792</pub-id></element-citation></ref><ref id="b0900"><label>180</label><element-citation publication-type="journal" id="h0900"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Z.</given-names></name></person-group><article-title>Clustering single-cell RNA-seq data with a model-based deep learning approach</article-title><source>Nat Mach Intell</source><volume>1</volume><year>2019</year><fpage>191</fpage><lpage>198</lpage></element-citation></ref><ref id="b0905"><label>181</label><element-citation publication-type="journal" id="h0905"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lyu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Susztak</surname><given-names>K.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name></person-group><article-title>Iterative transfer learning with neural network for clustering and cell type classification in single-cell RNA-seq analysis</article-title><source>Nat Mach Intell</source><volume>2</volume><year>2020</year><fpage>607</fpage><lpage>618</lpage><pub-id pub-id-type="pmid">33817554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42256-020-00233-7</pub-id><pub-id pub-id-type="pmcid">PMC8009055</pub-id></element-citation></ref><ref id="b0910"><label>182</label><element-citation publication-type="journal" id="h0910"><person-group person-group-type="author"><name name-style="western"><surname>Brbic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zitnik</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pisco</surname><given-names>A.O.</given-names></name><name name-style="western"><surname>Altman</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Darmanis</surname><given-names>S.</given-names></name><etal/></person-group><article-title>MARS: discovering novel cell types across heterogeneous single-cell experiments</article-title><source>Nat Methods</source><volume>17</volume><year>2020</year><fpage>1200</fpage><lpage>1206</lpage><pub-id pub-id-type="pmid">33077966</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41592-020-00979-3</pub-id></element-citation></ref><ref id="b0915"><label>183</label><element-citation publication-type="journal" id="h0915"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Miscell: an efficient self-supervised learning approach for dissecting single-cell transcriptome</article-title><source>iScience</source><volume>24</volume><year>2021</year><fpage>103200</fpage><pub-id pub-id-type="pmid">34712916</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.isci.2021.103200</pub-id><pub-id pub-id-type="pmcid">PMC8529514</pub-id></element-citation></ref><ref id="b0920"><label>184</label><element-citation publication-type="journal" id="h0920"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Su</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name></person-group><article-title>scGCN is a graph convolutional networks algorithm for knowledge transfer in single cell omics</article-title><source>Nat Commun</source><volume>12</volume><year>2021</year><fpage>3826</fpage><pub-id pub-id-type="pmid">34158507</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-021-24172-y</pub-id><pub-id pub-id-type="pmcid">PMC8219725</pub-id></element-citation></ref><ref id="b0925"><label>185</label><element-citation publication-type="journal" id="h0925"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Mogonet integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification</article-title><source>Nat Commun</source><volume>12</volume><year>2021</year><fpage>3445</fpage><pub-id pub-id-type="pmid">34103512</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-021-23774-w</pub-id><pub-id pub-id-type="pmcid">PMC8187432</pub-id></element-citation></ref><ref id="b0930"><label>186</label><element-citation publication-type="journal" id="h0930"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name></person-group><article-title>Multi-omics cancer prognosis analysis based on graph convolution network</article-title><source>Proceedings (IEEE Int Conf Bioinformatics Biomed)</source><volume>2021</volume><year>2021</year><fpage>1564</fpage><lpage>1568</lpage></element-citation></ref><ref id="b0935"><label>187</label><element-citation publication-type="journal" id="h0935"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.D.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Q.</given-names></name><etal/></person-group><article-title>Advances in multimodal data fusion in neuroimaging: overview, challenges, and novel orientation</article-title><source>Inf Fusion</source><volume>64</volume><year>2020</year><fpage>149</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">32834795</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.inffus.2020.07.006</pub-id><pub-id pub-id-type="pmcid">PMC7366126</pub-id></element-citation></ref><ref id="b0940"><label>188</label><element-citation publication-type="journal" id="h0940"><person-group person-group-type="author"><name name-style="western"><surname>Stuart</surname><given-names>T.</given-names></name><name name-style="western"><surname>Butler</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hoffman</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hafemeister</surname><given-names>C.</given-names></name><name name-style="western"><surname>Papalexi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Mauck</surname><given-names>W.M.</given-names><suffix>3rd</suffix></name><etal/></person-group><article-title>Comprehensive integration of single-cell data</article-title><source>Cell</source><volume>177</volume><year>2019</year><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="pmid">31178118</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2019.05.031</pub-id><pub-id pub-id-type="pmcid">PMC6687398</pub-id></element-citation></ref><ref id="b0945"><label>189</label><element-citation publication-type="journal" id="h0945"><person-group person-group-type="author"><name name-style="western"><surname>Subramanian</surname><given-names>I.</given-names></name><name name-style="western"><surname>Verma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jere</surname><given-names>A.</given-names></name><name name-style="western"><surname>Anamika</surname><given-names>K.</given-names></name></person-group><article-title>Multi-omics data integration, interpretation, and its application</article-title><source>Bioinform Biol Insights</source><volume>14</volume><year>2020</year><comment>1177932219899051</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1177932219899051</pub-id><pub-id pub-id-type="pmcid">PMC7003173</pub-id><pub-id pub-id-type="pmid">32076369</pub-id></element-citation></ref><ref id="b0950"><label>190</label><element-citation publication-type="journal" id="h0950"><person-group person-group-type="author"><name name-style="western"><surname>Welch</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Kozareva</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vanderburg</surname><given-names>C.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Macosko</surname><given-names>E.Z.</given-names></name></person-group><article-title>Single-cell multi-omic integration compares and contrasts features of brain cell identity</article-title><source>Cell</source><volume>177</volume><year>2019</year><fpage>1873</fpage><lpage>1887</lpage><pub-id pub-id-type="pmid">31178122</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2019.05.006</pub-id><pub-id pub-id-type="pmcid">PMC6716797</pub-id></element-citation></ref><ref id="b0955"><label>191</label><element-citation publication-type="journal" id="h0955"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Eran</surname><given-names>A.</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>N.</given-names></name><name name-style="western"><surname>Avillach</surname><given-names>P.</given-names></name><name name-style="western"><surname>Levy-Moonshine</surname><given-names>A.</given-names></name><name name-style="western"><surname>Szolovits</surname><given-names>P.</given-names></name><etal/></person-group><article-title>A multidimensional precision medicine approach identifies an autism subtype characterized by dyslipidemia</article-title><source>Nat Med</source><volume>26</volume><year>2020</year><fpage>1375</fpage><lpage>1379</lpage><pub-id pub-id-type="pmid">32778826</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-020-1007-0</pub-id></element-citation></ref><ref id="b0960"><label>192</label><element-citation publication-type="journal" id="h0960"><person-group person-group-type="author"><name name-style="western"><surname>Diao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name></person-group><article-title>Bridging the gap between outputs: domain adaptation for lung cancer IHC segmentation</article-title><source>IEEE Int Conf Image Process</source><year>2021</year><fpage>6</fpage><lpage>10</lpage></element-citation></ref><ref id="b0965"><label>193</label><element-citation publication-type="journal" id="h0965"><person-group person-group-type="author"><name name-style="western"><surname>Lotfollahi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Naghipourfar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Luecken</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Khajavi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Buttner</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wagenstetter</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Mapping single-cell data to reference atlases by transfer learning</article-title><source>Nat Biotechnol</source><volume>40</volume><year>2022</year><fpage>121</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">34462589</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41587-021-01001-7</pub-id><pub-id pub-id-type="pmcid">PMC8763644</pub-id></element-citation></ref><ref id="b0970"><label>194</label><element-citation publication-type="journal" id="h0970"><person-group person-group-type="author"><name name-style="western"><surname>Arrieta</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Diaz-Rodriguez</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ser</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Bennetot</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tabik</surname><given-names>S.</given-names></name><name name-style="western"><surname>Barbado</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Explainable artificial intelligence (XAI): concepts, taxonomies, opportunities and challenges toward responsible AI</article-title><source>Inf Fusion</source><volume>58</volume><year>2020</year><fpage>82</fpage><lpage>115</lpage></element-citation></ref><ref id="b0975"><label>195</label><element-citation publication-type="journal" id="h0975"><person-group person-group-type="author"><name name-style="western"><surname>Salahuddin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Woodruff</surname><given-names>H.C.</given-names></name><name name-style="western"><surname>Chatterjee</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lambin</surname><given-names>P.</given-names></name></person-group><article-title>Transparency of deep neural networks for medical image analysis: a review of interpretability methods</article-title><source>Comput Biol Med</source><volume>140</volume><year>2021</year><object-id pub-id-type="publisher-id">105111</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.compbiomed.2021.105111</pub-id><pub-id pub-id-type="pmid">34891095</pub-id></element-citation></ref><ref id="b0980"><label>196</label><element-citation publication-type="journal" id="h0980"><person-group person-group-type="author"><name name-style="western"><surname>Antoniadi</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Du</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Guendouz</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mazo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Becker</surname><given-names>B.A.</given-names></name><etal/></person-group><article-title>Current challenges and future opportunities for XAI in machine learning-based clinical decision support systems: a systematic review</article-title><source>Appl Sci</source><volume>11</volume><year>2021</year><fpage>5088</fpage></element-citation></ref><ref id="b0985"><label>197</label><element-citation publication-type="journal" id="h0985"><person-group person-group-type="author"><name name-style="western"><surname>Kourou</surname><given-names>K.</given-names></name><name name-style="western"><surname>Exarchos</surname><given-names>K.P.</given-names></name><name name-style="western"><surname>Papaloukas</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sakaloglou</surname><given-names>P.</given-names></name><name name-style="western"><surname>Exarchos</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fotiadis</surname><given-names>D.I.</given-names></name></person-group><article-title>Applied machine learning in cancer research: a systematic review for patient diagnosis, classification and prognosis</article-title><source>Comput Struct Biotechnol J</source><volume>19</volume><year>2021</year><fpage>5546</fpage><lpage>5555</lpage><pub-id pub-id-type="pmid">34712399</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.csbj.2021.10.006</pub-id><pub-id pub-id-type="pmcid">PMC8523813</pub-id></element-citation></ref><ref id="b0990"><label>198</label><mixed-citation publication-type="other" id="h0990">Maier-Hein L, Reinke A, Godau P, Tizabi MD, Christodoulou E, Glocker B, et al. Metrics reloaded: pitfalls and recommendations for image analysis validation. arXiv 2022;2206.01653.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41592-023-02151-z</pub-id><pub-id pub-id-type="pmcid">PMC11182665</pub-id><pub-id pub-id-type="pmid">38347141</pub-id></mixed-citation></ref><ref id="b0995"><label>199</label><element-citation publication-type="journal" id="h0995"><person-group person-group-type="author"><name name-style="western"><surname>Meropol</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Donegan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rich</surname><given-names>A.S.</given-names></name></person-group><article-title>Progress in the application of machine learning algorithms to cancer research and care</article-title><source>JAMA Netw Open</source><volume>4</volume><year>2021</year><fpage>e2116063</fpage><pub-id pub-id-type="pmid">34232307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2021.16063</pub-id></element-citation></ref><ref id="b1000"><label>200</label><element-citation publication-type="journal" id="h1000"><person-group person-group-type="author"><name name-style="western"><surname>Sheehan</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Criss</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.F.</given-names></name><name name-style="western"><surname>Eckel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Palazzo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tramontano</surname><given-names>A.C.</given-names></name><etal/></person-group><article-title>Lung cancer costs by treatment strategy and phase of care among patients enrolled in medicare</article-title><source>Cancer Med</source><volume>8</volume><year>2019</year><fpage>94</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">30575329</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cam4.1896</pub-id><pub-id pub-id-type="pmcid">PMC6346221</pub-id></element-citation></ref><ref id="b1005"><label>201</label><element-citation publication-type="journal" id="h1005"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name></person-group><article-title>MedGCN: medication recommendation and lab test imputation via graph convolutional networks</article-title><source>J Biomed Inform</source><volume>127</volume><year>2022</year><object-id pub-id-type="publisher-id">104000</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jbi.2022.104000</pub-id><pub-id pub-id-type="pmcid">PMC8901567</pub-id><pub-id pub-id-type="pmid">35104644</pub-id></element-citation></ref><ref id="b1010"><label>202</label><element-citation publication-type="journal" id="h1010"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Prediction of drug efficacy from transcriptional profiles with deep learning</article-title><source>Nat Biotechnol</source><volume>39</volume><year>2021</year><fpage>1444</fpage><lpage>1452</lpage><pub-id pub-id-type="pmid">34140681</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41587-021-00946-z</pub-id></element-citation></ref><ref id="b1015"><label>203</label><element-citation publication-type="journal" id="h1015"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wunderink</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Lloyd-Jones</surname><given-names>D.</given-names></name></person-group><article-title>Proactive vs reactive machine learning in health care: lessons from the COVID-19 pandemic</article-title><source>JAMA</source><volume>327</volume><year>2022</year><fpage>623</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">35085382</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2021.24935</pub-id></element-citation></ref><ref id="b1020"><label>204</label><element-citation publication-type="journal" id="h1020"><person-group person-group-type="author"><name name-style="western"><surname>You</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>C.X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.B.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Y.L.</given-names></name><etal/></person-group><article-title>Concordance of treatment recommendations for metastatic non-small-cell lung cancer between watson for oncology system and medical team</article-title><source>Cancer Manag Res</source><volume>12</volume><year>2020</year><fpage>1947</fpage><lpage>1958</lpage><pub-id pub-id-type="pmid">32214852</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/CMAR.S244932</pub-id><pub-id pub-id-type="pmcid">PMC7083631</pub-id></element-citation></ref><ref id="b1025"><label>205</label><element-citation publication-type="journal" id="h1025"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>M.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>C.</given-names></name></person-group><article-title>Using artificial intelligence (watson for oncology) for treatment recommendations amongst chinese patients with lung cancer: feasibility study</article-title><source>J Med Internet Res</source><volume>20</volume><year>2018</year><fpage>e11087</fpage><pub-id pub-id-type="pmid">30257820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/11087</pub-id><pub-id pub-id-type="pmcid">PMC6231834</pub-id></element-citation></ref></ref-list><sec id="s0115" sec-type="supplementary-material"><title>Supplementary material</title><p id="p0120">The following are the Supplementary data to this article:<supplementary-material content-type="local-data" id="m0010" position="float" orientation="portrait"><caption><title>Supplementary Table S1</title><p><bold>Lung cancer benchmark datasets used by the machine learning methods reviewed in this paper</bold></p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc1.docx" position="float" orientation="portrait"/></supplementary-material></p><p id="p0125">
<supplementary-material content-type="local-data" id="m0005" position="float" orientation="portrait"><caption><title>Supplementary Table S2</title><p><bold>Machine learning methods used for benchmark studies in lung cancer therapy</bold></p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc2.docx" position="float" orientation="portrait"/></supplementary-material>
</p></sec><ack id="ak005"><title>Acknowledgments</title><p id="p0110">This study is supported in part by the National Institutes of Health, USA (Grant Nos. U01TR003528 and R01LM013337).</p></ack><fn-group><fn id="d35e1211"><p id="np005">Peer review under responsibility of Beijing Institute of Genomics, Chinese Academy of Sciences / China National Center for Bioinformation and Genetics Society of China.</p></fn><fn id="s0110" fn-type="supplementary-material"><p id="p0115">Supplementary data to this article can be found online at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.gpb.2022.11.003" id="ir005">https://doi.org/10.1016/j.gpb.2022.11.003</ext-link>.</p></fn></fn-group></back></article></pmc-articleset>